Scientific publications
Since the foundation of Syreon Research Institute in 2008 our researchers have published several hundreds of scientific papers, especially in the fields of health economics, health policy, health technology assessment, epidemiology and public health in prestigious scientific journals. In addition to peer-reviewed articles, our colleagues edited several books, co-authored several book chapters and white papers and contributed to major international conferences.
2024
Ágh, T., Hiligsmann, M., Borah, B., Beaudart, C., Turcu-Stiolica, A., Manias, E., Jakab, I., Pednekar, P., Zeber, J., Peterson, A. M. (2024). Systematic Review of Outcomes for Assessment of Medication Adherence Enhancing Interventions: An ISPOR Special Interest Group Report. Value in Health. doi: 10.1016/j.jval.2023.10.016 Link
Alnaqbi, K. A., Elezbawy, B., Fasseeh, A. N., Bangash, A. R., Elshamy, A., Shendi, H., Aftab, M. I., AlMarshoodi, M., Gebran, N., AlDhaheri, N., Fahmy, S. A., Al Dallal, S., Al Naeem, W., Abaza, S., Kaló, Z. (2024). Development of the Emirates Multi-Criteria Decision Analysis Tool for Orphan Drugs. Cureus. doi:10.7759/cureus.55215 Link
Árva, D., Vokó, Z., Sápi, M., Cselkó, Zs., Rákosy, Zs. (2024). The influence of institutional characteristics on implementing school-based universal addiction prevention: a Hungarian mixed-methods nationwide study on the state of implementation, barriers, and facilitators. Frontiers in Education. doi: 10.3389/feduc.2023.1240909 Link
DiStefano, M. J., Zemplenyi, A., McQueen, R. B. (2024). Assessing clinical benefit in the Medicare Drug Price Negotiation Program: A 2-step approach for improving transparency, consistency, and meaningful patient engagement. Journal of Managed Care & Specialty Pharmacy. doi: 10.18553/jmcp.2024.23255 Link
Kovačević, I. N., Vujović, A., Stanišić, M., Vuković-Leković, J., Lansdorp-Vogelaar, I., Mlakar, D. N., Senore, C., Józwiak-Hagymásy, J., Széles, Gy., Vokó, Z., Csanádi, M. (2024). Roadmap to improve the organized cancer screening programs – The case of colorectal cancer screening in Montenegro. Journal of Cancer Policy. doi:10.1016/j.jcpo.2023.100464 Link
Milanic, M., Hren, R. (2024). GPU Adding-Doubling Algorithm for Analysis of Optical Spectral Images. Algorithms. doi: 10.3390/a17020074 Link
Milanic, M., Hren, R., Stergar, J., Simoncic, U. (2024). Monitoring of Caffeine Consumption Effect on Skin Blood Properties by Diffuse Reflectance Spectroscopy. Physiological Research. doi: 10.33549/physiolres.935138 Link
Molnár, G. A., Vokó, Z., Sütő, G., Rokszin, Gy., Nagy, D., Surján, Gy., Surján, O., Nagy, P., Kenessey, I., Wéber, A., Pálosi, M., Müller, C., Kásler, M., Wittmann, I., Kiss, Z. (2024). Effectiveness of SARS-CoV-2 primary vaccines and boosters in patients with type 2 diabetes mellitus in Hungary (HUN-VE 4 Study). BMJ Open Diabetes Research and Care. doi: 10.1136/bmjdrc-2023-003777 Link
Simoens, S., Lacosta, T. B., Inotai, A. (2024). Learnings from cross-border biosimilar pricing policies in Europe. Expert Review of Pharmacoeconomics & Outcomes Research. doi: 10.1080/14737167.2024.2334343 Link
van Boven, J.F.M., Lavorini, F., Agh, T., Sadatsafavi, M., Patino, O., Muresan, B. (2024) Cost-effectiveness and impact on healthcare utilization of interventions to improve medication adherence and outcomes in asthma and COPD: A systematic literature review. The Journal of Allergy and Clinical Immunology: In Practice. doi: 10.1016/j.jaip.2023.12.049. Link
Wennekes, M.D., Almási, T., Eilers, R., Mezei, F., Petykó, Zs. I., Timen, A., Vokó, Z. (2024). Effectiveness of educational interventions for healthcare workers on vaccination dialogue with older adults: a systematic review. Archives of Public Health. doi: 10.1186/s13690-024-01260-1 Link
2023
Ágh, T., Hiligsmann, M., Borah, B., Beaudart, C., Turcu-Stiolica, A., Manias, E., Jakab, I., Pednekar, P., Zeber, J., Peterson, A.M. (2023). A Systematic Review of Outcomes for Assessment of Medication Adherence Enhancing Interventions – An ISPOR Special Interest Group Report. Value in Health. doi: 10.1016/j.jval.2023.10.016 Link
Ágh, T., van Boven, J. F. M., Kardas, P. (2023). Europe’s cost of living crisis jeopardises medication adherence. BMJ. doi: 10.1136/bmj.p747 Link
Alamer, M., Kaló, Z., Schuller, T., Almomani, E., AlQutob, R. (2023). Understanding of the Readiness for HTA Implementation in Jordan as a Step Towards Universal Health Coverage. Jordan Medical Journal. doi: 10.35516/jmj.v57i1.1103 Link
AlRashdi, I., Albalushi, S., Alshuaili, A., AlRashdi, S., Al Bulushi, N. I., Al kindi, A. I., Korra, N., Fasseeh, A., Abaza, S., Kaló, Z. (2023). HTA355 A Roadmap Towards Implementing HTA in Oman. Value in Health. doi: 10.1016/j.jval.2023.09.2038 Link
Árva, D., Vokó, Z., Sápi, M., Cselkó, Z., Rákosy, Z. (2023). Addiction prevention & mental health support in Hungarian elementary schools: a mixed-methods study, European Journal of Public Health. doi: 10.1093/eurpub/ckad160.1524 Link
Árva, D., Vokó, Z., Sápi, M., Cselkó, Zs., Rákosy, Zs. (2023). The Influence of Institutional Characteristics on Implementing Schoolbased Universal Addiction Prevention: A Hungarian Mixed-Methods Nationwide Study on the State of Implementation, Barriers, and Facilitators. Frontiers in Education. doi: 10.3389/feduc.2023.1240909 Link
Babarczy, B., Józwiak-Hagymásy, J., Ameyaw, D., Obeng, G. D., Zelei, T., Szeles, G., Banerjee, G., Sikirica, V. (2023). EE702 Humanistic and Economic Burden of Methylmalonic Acidemia—A Systematic Literature Review. Value in Health. doi: 10.1016/j.jval.2023.09.967 Link
Callenbach, M.H. E., Ádám, I., Vreman, R. A., Németh, B., Kaló, Z., Goettsch, W. G. (2023). Reimbursement and payment models in Central and Eastern European as well as Middle Eastern countries: A survey of their current use and future outlook. Drug Discovery Today. doi: 10.1016/j.drudis.2022.103433 Link
Choon-Quinones, M., Hose, D., Kaló, Z., Zelei, T., Harousseau, J-L., Durie, B., Keown, P., Barnett, M., Jakab, I. (2023). Patient and Caregiver Experience Decision Factors in Treatment Decision Making—Results of a Systematic Literature Review of Multiple Myeloma Decision Aids. Value in Health. doi: 10.1016/j.jval.2022.04.003 Link
Choon-Quinones, M., Zelei, T., Németh, B., Tóth, M., Jia, X. Y., Barnett, M., Keown, P., Durie, B., Harousseau, J-L, Hose, D., Kaló, Z. (2023). Systematic literature review of health economic models developed for multiple myeloma to support future analyses. Journal of Medical Economics. doi: 10.1080/13696998.2022.2144056 Link
Elezbawy, B., Fasseeh, A. N., Fouly, E., Tannira, M., Dalle, H., Aderian, S., Abu Esba, L. C., Al Abdulkarim, H., Ammoury, A., Altawil, E., Al Turaiki, A., Albreiki, F., Al-Haddab, M., Al-Lafi, A., Alowayesh, M., Al-Sheikh, A., Elsayed, M., Elshamy, A., Eshmawi, M., Farag, A., Hamadah, I., Hedibel, M., Kannenberg, S., Karam, R., Metni, M., Raboobee, N., Steinhoff, M., Abaza, S., Farghaly, M., Kaló, Z. (2023). Humanistic and Economic Burden of Atopic Dermatitis for Adults and Adolescents in the Middle East and Africa Region. Dermatology and Therapy. doi: 10.1007/s13555-022-00857-0 Link
Elvidge, J., Summerfield, A., Knies, S., Németh, B., Kaló, Z., Goettsch, W., Dawoud, D. (2023). Health technology assessment of tests for SARS-CoV-2 and treatments for COVID-19: A proposed approach and best-practice recommendations. International Journal of Technology Assessment in Health Care. doi:10.1017/S0266462323000223 Link
Fasseeh, A.N., Elezbawy, B., El-Fass, K.A., GamaI, M., Seyam, A., Hayek, N., Rahman, N.A., Abdelhamid, S., Fasseeh, N., Saad, A.S., Elagamy, A., Mahmoud, A., Sedrak, A.S., Elshazly, K., Eldebeiky, M., Talaat, M., Mohamed, N.M., Abdelaziz, R.A., Refaat, R., Akeel, S., Abaza, S., Kaló, Z. (2023). Maximizing the benefits of using biosimilars in Egypt. Journal of Pharmaceutical Policy and Practice. doi: 10.1186/s40545-023-00581-w Link
Fasseeh, A., Salem, A. A., Rasmy, A .M., El Gendy, H. , Szilberhorn, L., Barakat, T., Radwan, M., Nagy, B. (2023). Cost-Effectiveness Analysis of Ceftazidime/Avibactam Versus Polymyxin E in The Treatment of Carbapenem-Resistant Enterobacteriaceae Infections: Literature Review. The Egyptian Journal of Hospital Medicine. doi: 10.21608/ejhm.2023.287325 Link
Hawksworth, C., Elvidge, J., Knies, S., Zemplenyi, A., Petykó, Zs. I., Siirtola, P., Chandra, G., Srivastava, D., Denniston, A., Chalkidou, A., Delaye, J., Nousios, P., Gomes, M., Saygın Avşar, T., Wang, J., Petrou, S., Dawoud, D. (2023). Protocol for the development of an artificial intelligence extension to the Consolidated Health Economic Evaluation Reporting Standards (CHEERS) 2022. doi: 10.1101/2023.05.31.23290788. Link
Huygens, S., Vellekoop, H., Versteegh, M., Santi, I., Szilberhorn, L., Zelei, T., Nagy, B., Tsiachristas, A., Koleva-Kolarova, R., Wordsworth, S., Rutten-van Mölken, M. (2023). Cost-Effectiveness Analysis of Treating Patients With NTRK-Positive Cancer With the Histology-Independent Therapy Entrectinib. Value in Health. doi: 10.1016/j.jval.2022.08.006 Link
Hren, R., Sersa, G., Simoncic, U., Milanic, M. (2023).
Ispán, F., Hegedüs, T., Csanádi, M., Nagy, B. (2023). A kockázatmegosztási megállapodások adminisztrációs terhei Magyarországon – Irány az automatizáció? - Administrative burden of managed entry agreements for pharmaceuticals in Hungary – towards automation?. IME. doi: 10.53020/IME-2023-407 Link
Jakab, I., Dimitrova, M., Houÿez, F., Bereczky, T., Fövényes, M., Maravic, Z., Belina, I., Andriciuc, C., Tóth, K., Piniazhko, O., Hren, R., Gutierrez-Ibarluzea, I., Czech, M., Tesar, T., Niewada, M., Lorenzovici, L., Kamusheva, M., Manova, M., Savova, A., Mitkova, Z., Tachkov, K., Németh, B., Petykó, Zs. I., Dawoud, D., Delnoij, D., Knies, S., Goettsch, W., Kaló, Z. (2023). Recommendations for patient involvement in health technology assessment in Central and Eastern European countries. Frontiers in Public Health. doi: 10.3389/fpubh.2023.1176200 Link
Kaló, Z., Niewada, M., Bereczky, T., Goettsch, W., Vreman, R. A., Xoxi, E., Trusheim, M., Callenbach, M. H. E., Nagy, L., Simoens, S. (2023) Importance of aligning the implementation of new payment models for innovative pharmaceuticals in European countries. Expert Review of Pharmacoeconomics & Outcomes Research. doi: 10.1080/14737167.2023.2282680 Link
Kárász, D., Erdősi D., Kardas, P., Lewek, P., Klimczak, P., Łojewska, E., Kovács, S., Zemplényi, A., Agh, T. (2023). MT34 Adaptation and Cost-Effectiveness Analysis of the "My Health Everyday” Medication Adherence Coaching Application for Hypertension Management in Hungary. Value in Health. doi: 10.1016/j.jval.2023.09.2263 Link
Kardas, P., Aarnio, E., Agh, T., van Boven, J. F. M., Dima, A. L., Ghiciuc, C. M., Kamberi, F., Petrova, G. I., Nabergoj, M. U., Trečiokienė, I. (2023). New terminology of medication adherence enabling and supporting activities: ENABLE terminology. Frontiers in Pharmacology. doi:10.3389/fphar.2023.1254291 Link
Kiss, Z., Gálffy. G., Müller, V., Moldvay, J., Sarosi, V., Pápai-Székely, Zs., Csada, E., Kerpel-Fronius, A., Király, Zs., Szász, Z., Hódi, G., Polányi, Z., Kovacs, K. A., Karamousouli, E., Knollmajer, K., Szabó, T. G., Berta, A., Vokó, Z., Rokszin, Gy., Abonyi-Tóth, Zs., Barcza, Zs., Tamási, L., Bogos, K. (2023). Significant Changes In Advanced Lung Cancer Survival During The Past Decade In Hungary: Impact Of Modern Immunotherapy and the Covid-19 Pandemic. Frontiers in Oncology. doi: 10.3389/fonc.2023.1207295 Link
Koleva-Kolarova, R., Szilberhorn, L., Zelei, T., Vellekoop, H., Nagy, B., Huygens, S., Versteegh, M., Rutten-van Mölken, M., Wordsworth, S., Tsiachristas, A. (2023). Financial incentives to promote personalized medicine in Europe: an overview and guidance for implementation. Personalized Medicine. doi: 10.2217/pme-2022-0145. Link
Koleva-Kolarova, R., Vellekoop, H., Huygens, S., Versteegh, M., Rutten-van Mölken, M., Szilberhorn, L., Zelei, T., Nagy, B., Wordsworth, S., Tsiachristas, A. (2023). Budget impact and transferability of cost–effectiveness of DPYD testing in metastatic breast cancer in three health systems. Personalized Medicine. doi: 10.2217/pme-2022-0133 Link
Koleva-Kolarova, R., Vellekoop, H., Huygens, S., Versteegh, M., Rutten-van Mölken, M., Szilberhorn, L., Zelei, T., Nagy, B., Wordsworth, S., Tsiachristas, A. (2023). Cost-effectiveness of extended DPYD testing before fluoropyrimidine chemotherapy in metastatic breast cancer in the UK. Personalized Medicine. doi: 10.2217/pme-2022-0099 Link
Kovács, G., Abonyi-Tóth, Z., Fadgyas-Freyler, P., Kaló, Z. (2023). Incremental cost of premature birth - a public health care payer perspective from Hungary. BMC Health Services Research. doi: 10.1186/s12913-023-09697-w Link
Kovács, G., Mohos, E., Kis, J. T., Tabák, Á., Gerendy, P., Dózsa, Cs., Dózsa, K., Pettkó, J., Ujhelyi, K., Kaló, Z. (2023). A bariátriai műtétek egészségpolitikai szerepe a 2-es típusú cukorbetegségben szenvedő elhízott betegek ellátásában. IME Innováció, Menedzsment, Egészségügy. doi: 10.53020/IME-2023-302 Link
Kovács, G., Mohos, E., Kis, J. T., Tabák, Á., Gerendy, P., Pettkó, J., Nagy, D., Győrbíró, D., Kaló, Z. (2023). Cost-Effectiveness of Bariatric Surgery in Patients Living with Obesity and Type 2 Diabetes. Journal of Diabetes Research. doi: 10.1155/2023/9686729 Link
Kovács, G., Nagy, D., Szilberhorn, L., Zelei, T., Gaál, Zs., Vellekoop, H., Huygens, S., Versteegh, M., Rutten-van Mölken, M., Koleva-Kolarova, R., Tsiachristas, A., Wordsworth, S., Nagy, B. (2023). Cost-effectiveness of genetic-based screening strategies for maturity-onset diabetes of the young. Personalized Medicine. doi: 10.2217/pme-2023-0023 Link
Lorenzovici, L., Szilberhorn, L., Farkas-Ráduly, S. Gasparik, A. I., Precup, A. M., Nagy, A. Gy., Niemann, C. U., Aittokallio, T., Kaló, Z., Csanádi, M. (2023). Systematic Literature Review of Economic Evaluations of Treatment Alternatives in Chronic Lymphocytic Leukemia. BioDrugs. doi: 10.1007/s40259-023-00583-9 Link
McQueen, R.B., Inotai, A., Zemplenyi, A., Mendola, N., Németh, B., Kalo, Z. (2023). Multi-Stakeholder Perceptions of Additional Value Elements for United States Value Assessment of Health Interventions. Value in Health. doi:10.1016/j.jval.2023.09.2910 Link
McQueen, R.B., Mendola, N.D., Jakab, I., Bennett, J., Nair, K.V., Németh, B., Inotai, A., Kaló, Z. (2023). Framework for Patient Experience Value Elements in Rare Disease: A Case Study Demonstrating the Applicability of Combined Qualitative and Quantitative Methods. PharmacoEconomics Open. doi: 10.1007/s41669-022-00376-w Link
Mészáros, A., Vokó, Z. (2023). Encouraging the planetary health diet via food taxes and subsidies: a model concept. European Journal of Public Health. doi: 10.1093/eurpub/ckad160.1069 Link
Moorkens, E., Lacosta, T. B., Dawoud, D., Inotai, A., Janodia, M., Tan, C. J., Lim, K. K., Khatri, N., Pereira, C. L., Simoens, S. (2023). A Systematic Literature Review of Gaps and Challenges in Value Assessment of Biosimilars: An ISPOR Special Interest Group Report. Value in Health. doi: 10.1016/j.jval.2023.04.007 Link
Mosli, M., Almutairdi, A., Abdulrahman, A.K., Fasseeh, A. N., Abd-El Aziz, A., Jaheen, A., Anwar, A., Elezbawy, B., Alharbi, B., Al Tawil, E., Al-Abdulkarim, H., Alqasim, H., Eldeeb, I., Ahmed El-Fass, K., Alanizy, L., Tannira, M., Almehizia, R., Abaza, S., Iskandarani, W., Kaló, Z. (2023). EE329 Budget Impact Analysis of Adding Risankizumab and Upadacitinib for the Treatment of Inflammatory Bowel Disease in the Kingdom of Saudi Arabia. Value in Health. doi: 10.1016/j.jval.2023.09.595 Link
Nagy, B., Győrbíró, D., Csanádi, M. (2023). A kis dózisú komputertomográfiával történő tüdőrákszűrés hazai bevezetésének kérdései. LEGE ARTIS MEDICINAE. doi: 10.33616/lam.33.0105 Link
Nagy, B., Szilberhorn, L., Győrbíró, D.M., Moizs, M., Bajzik, G., Kerpel-Fronius, A., Vokó, Z. (2023). Shall We Screen Lung Cancer With Low-Dose Computed Tomography? Cost-Effectiveness in Hungary. Value in Health Regional Issues. doi: 10.1016/j.vhri.2022.10.002 Link
Nagy, B., Zelei, T., Vellekoop, H., Huygens, S., Versteegh, M., Rutten-van Mölken, M., R., Koleva-Kolarova, Tsiachristas, A., Wordsworth, S., Szilberhorn, L. (2023). Lessons learned from the application of the HEcoPerMed guidance to three modeling case studies. Personalized Medicine. doi: 10.2217/pme-2023-0040 Link
Németh, B., Kamusheva, M., Mitkova, Z., Petykó, Zs. I., Zemplényi, A., Dimitrova, M., Tachkov, K., Balkányi, L., Czech, M., Dawoud, D., Goettsch, W., Hren, R., Knies, S., Lorenzovici, L., Maravic, Z., Piniazhko, O., Zerovnik, S., Kaló, Z. (2023). Guidance on using real-world evidence from Western Europe in Central and Eastern European health policy decision making. Journal of Comparative Effectiveness Research. doi: 10.57264/cer-2022-0157 Link
Németh, G., Mágó, M.L., Kaló, Z., Lám, J., Balogh, T., Brodszky, V. (2023). A concept for multi-winner tenders for medicinal products with balancing between efficient prices, long-term competition and sustainability of supply. Frontiers in Medicine. doi: 10.3389/fmed.2023.1282698 Link
Pham, T. H., Beck, E., Postma, M. J., Németh, B., Ágh, T., de Waure, C., Salisbury, D.M., Nutma, N., van der Schans, J. (2023). Country score tool to assess readiness and guide evidence generation of immunization programs in ageing adults in Europe. Frontiers in Public Health. doi: 10.3389/fpubh.2022.1080678 Link
Pitter, J.G., Zemplényi, A., Babarczy, B., Németh, B., Kaló, Z., Vokó, Z. (2023). Frailty prevalence in 42 European countries by age and gender: development of the SHARE Frailty Atlas for Europe. GeroScience. doi: 10.1007/s11357-023-00975-3 Link
Rutten-van Mölken, M., Versteegh, M., Nagy, B., Wordsworth, S. (2023). HEcoPerMed, personalized medicine from a health economic perspective: lessons learned and potential opportunities ahead. Personalized Medicine. doi: 10.2217/pme-2022-0074 Link
Sayour, N. V., Brenner, G. B., Makkos, A., Kiss, B., Kovácsházi, Cs., Gergely, T. G., Aukrust, S. G., Tian, H., Zenkl, V., Gömöri, K., Szabados, T., Bencsik, P., Heinen, A., Schulz, R., Baxter, G. F., Zuurbier, C. J., Vokó, Z., Ferdinandy, P., Giricz, Z. (2023). Cardioprotective efficacy of limb remote ischaemic preconditioning in rats: discrepancy between a meta-analysis and a three-centre in vivo study. Cardiovascular Research. doi: 10.1093/cvr/cvad024 Link
Staniszewska, S., Jakab, I., Low, E., Mossman, J., Posner, P., Husereau, D., Stephens, R., Drummond, M. (2023). Commentary: Advocating for patient and public involvement and engagement in health economic evaluation. Research Involvement and Engagement. doi: 10.1186/s40900-023-00444-3 Link
Szekanecz, Z., Vokó, Z., Surján, O., Rákóczi, É., Szamosi, S., Szűcs, G., Szekanecz, É., Müller, C., Kiss, Z. (2023). Effectiveness and waning of protection with the BNT162b2 vaccine against the SARS-CoV-2 Delta variant in immunocompromised individuals. Frontiers in Immunology. doi: 10.3389/fimmu.2023.1247129 Link
Szilberhorn, L., Zelei, T., Vellekoop, H., Huygens, S., Versteegh, M., Rutten-van Mölken, M., Koleva-Kolarova, R., Tsiachristas, A., Wordsworth, S., Nagy, B. (2023). Cost–effectiveness and budget impact analysis of screening strategies for maturity-onset diabetes of the young in three European countries. Personalized Medicine. Doi: 10.2217/pme-2023-0017 Link
Tittmann, J., Csanádi, M., Ágh, T., Széles, Gy., Vokó, Z., Kallai, Á. (2023). Development of a breast cancer screening protocol to use automated breast ultrasound in a local setting. Frontiers in Public Health. doi: 10.3389/fpubh.2022.1071317 Link
Vellekoop, H., Huygens, S., Versteegh, M., Szilberhorn, L., Zelei, T., Nagy, B., Koleva-Kolarova, R., Wordsworth, S., Rutten-van Mölken, M. (2023). Cost–effectiveness of alternative NTRK testing strategies in cancer patients followed by histology-independent therapy with entrectinib: an analysis of three European countries. Personalized Medicine. doi: 10.2217/pme-2022-0070 Link
Wennekes, M.D., Eilers, R., Caputo, A., Gagneaux-Brunon, A., Gavioli, R., Nicoli, F., Vokó, Z., Timen, A. (2023). Focus group study on perceptions and information needs regarding vaccines targeting the older population: a cross-country comparison in four European countries. GeroScience. doi: 10.1007/s11357-022-00682-5 Link
Wennekes, M.D., Eilers, R., Stein, M.L., Caputo, A., Gagneux-Brunon, A., Gavioli, R., Nicoli, F., Biesheuvel, J., Vokó, Z., Timen, A. (2023). Information networks of healthcare professionals in Europe on older adult vaccines: Network analysis. European Journal of Public Health. doi: 10.1093/eurpub/ckad160.1481 Link
Zelei, T., Kovács, S., Finn, P., Nagy, D., Sikirica, V., Carlson, K. B., Vokó, Z. (2023). Systematic literature review of the epidemiology of glycogen storage disease type 1a. Journal of Pediatric Endocrinology and Metabolism. doi: 10.1515/jpem-2023-0127 Link
Zemplényi, A., Tachkov, K., Balkanyi, L., Németh, B., Petykó, Zs. I., Petrova, G., Czech, M., Dawoud, D., Goettsch, W., Gutierrez, I. I., Hren, R., Knies, S., Lorenzovici, L., Maravic, Z., Piniazhko, O., Savova, A., Manova, M., Tesar, T., Zerovnik, S., Kaló, Z. (2023). Recommendations to overcome barriers to the use of artificial intelligence-driven evidence in health technology assessment. Frontiers in Public Health. doi: 10.3389/fpubh.2023.1088121 Link
Zielonke, N., Senore, C., Ponti, A., Csanádi, M., de Koning, H. J., Heijnsdijk, E. A. M., van Ravesteyn, N. T. (2023). Overcoming barriers: Modelling the effect of potential future changes of organized breast cancer screening in Italy. Journal of Medical Screening. doi:10.1177/09691413231153568 Link
2022
Ádám, I., Callenbach, M., Németh, B., Vreman, R.A., Tollin, C., Pontén, J., Dawoud, D., Elvidge, J., Crabb, N., van Waalwijk van Doorn-Khosrovani, S.B., Pisters-van Roy, A., Vincziczki, Á., Almomani, E., Vajagic, M., Oner, Z.G., Matni, M., Fürst, J., Kahveci, R., Goettsch, W.G., Kaló, Z. (2022). Outcome-based reimbursement in Central-Eastern Europe and Middle-East. Frontiers in Medicine. doi: 10.3389/fmed.2022.940886 Link
Ádám, I., Callenbach, M., Németh, B., Vreman, R. A., Pontén, J., Strbad, T., Dawoud, D., Kostyuk, A., Seyam, A., Nagy, L., Goettsch, W. G., Kaló, Z. (2022). Delayed payment schemes in Central-Eastern Europe and Middle-East. Frontiers in Medicine. doi: 10.3389/fmed.2022.940371 Link
Ágh, T., Hadžiabdić, M. O., Garuoliene K., Granas, A.G., Aarnio, E., Menditto, E., Gregório J., Barnestein-Fonseca, P., Mevsim, V., Kardas, P., European Network to Advance Best Practices and Technology on Medication Adherence (ENABLE). (2022). Reimbursed Medication Adherence Enhancing Interventions in European Countries: Results of the EUREcA Study. Frontiers in Pharmacology. doi: 10.3389/fphar.2022.892240 Link
Ágh, T., Szilberhorn, L., Csanádi, M., Széles, G., Vokó, Z., Ádám, G., Kallai, Á. (2022). A kis sugárdózisú komputertomográfia szerepe a tüdőrákszűrésben. Orvosi Hetilap. doi: 10.1556/650.2022.32583 Link
Ágh, T., van Boven, J. F. M., Wettermark, B., Menditto, E., Pinnock, H., Tsiligianni, I., Kardas, P. (2022). Medication Management Practices for Noncommunicable Diseases During the COVID-19 Pandemic: A Snapshot of the European Situation. Value & Outcomes Spotlight. Link
Almomani, E., Hammad, E. A., AlQutob, R., Hammour, K. A., Al-Sharu, E., Abu-Shaer, M., Alabbadi, I., Kaló, Z. (2022). Capacity Building for Health Technology Assessment in Jordan: Institutionalization and Its Use in Pricing and Reimbursement Decisions. Value in Health Regional Issues. doi: 10.1016/j.vhri.2022.07.006 Link
Choon-Quinones, M., Zelei, T., Barnett, M., Keown, P., Durie, B., Kaló, Z., Almási, T., Harousseau, J.L., Hose, D. (2022). Beyond medicines' barriers: exploring the true cost of multiple myeloma. Journal of Medical Economics. doi: 10.1080/13696998.2022.2133823 Link
Csanádi, M., Ágh, T., Tordai, A., Tapprich, C., Vokó, Z., Stamatopoulos, K. (2022). Secondary primary malignancies after treatment with chemo-immunotherapy in treatment-naïve patients with CLL: a systematic literature review. Expert Review of Hematology. doi: 10.1080/17474086.2022.2042246 Link
Csanádi, M., Kaló, Z., Rutten-van Molken, M., Looman, W., Huic, M., Ercevic, D., Atanasijevic, D., Lorenzovici, L., Petryszyn, P., Pogány, G., Pitter, J., Zemplényi, A. (2022). Prioritization of implementation barriers related to integrated care models in Central and Eastern European countries. Health Policy. doi: 10.1016/j.healthpol.2022.08.012. Link
Dimitrova, M., Jakab, I., Mitkova, Z., Kamusheva, M., Tachkov, K., Németh, B., Zemplényi, A., Dawoud, D., Delnoij, D. M. J., Houýez, F., Kaló, Z. (2022). Potential Barriers of Patient Involvement in Health Technology Assessment in Central and Eastern European Countries. Frontiers in Public Health. doi: 10.3389/fpubh.2022.922708 Link
Drummond, M., Federici, C., Reckers-Droog, V., Torbica, A., Blankart, C.R., Ciani, O., Kaló, Z., Kovács, S., Brouwer, W. (2022). Coverage with evidence development for medical devices in Europe: Can practice meet theory? Health Economics. doi:10.1002/hec.4478 Link
Elek, P., Csanádi, M., Fadgyas-Freyler, P., Gervai, N., Oross-Bécsi, R., Szécsényi-Nagy, B., Tatár, M., Váradi, B., Zemplényi, A. (2022). Heterogeneous impact of the COVID-19 pandemic on lung, colorectal and breast cancer incidence in Hungary: results from time series and panel data models. BMJ Open. doi: Link
Elek, P., Fadgyas-Freyler, P., Váradi, B., Mayer, B., Zemplényi, A., Csanádi, M. (2022). Effects of lower screening activity during the COVID-19 pandemic on breast cancer patient pathways: Evidence from the age cut-off of organized screening. Health Policy. doi: 10.1016/j.healthpol.2022.05.013 Link
Elezbawy, B., Fasseeh, A. N., Fouly, E., Abu Esba, L. C., Al Abdulkarim, H., Al-Haddab, M., Al-Sheikh, A., Altawil, E., Al Turaiki, A., Eshmawi, M., Hamadah, I., Tannira, M., Dalle, H., Aderian, S., Roshdy, A., Jaheen, A., Hamad, T., Abaza, S., Kaló, Z. (2022). The humanistic and economic burden of atopic dermatitis among adults and adolescents in Saudi Arabia. Journal of Medical Economics. doi: 10.1080/13696998.2022.2152234 Link
Elezbawy, B., Fasseeh, A. N., Németh, B., Gamal, M., Eldebeiky, M., Refaat, R., Taha, A., Rabiea, S., Abdallah, M., Ramadan, S., Noaman, H., Eldin, A. B., Mostafa, H., Nouh, S., Zaki, A., Abdelrahman, M., Abaza, S., Kaló, Z. (2022). A multicriteria decision analysis (MCDA) tool to purchase implantable medical devices in Egypt. BMC Medical Informatics and Decision Making. doi: 10.1186/s12911-022-02025-y Link
Elezbawy, B., Fasseeh, A.N., Sedrak, A., Eldessouki, R., Gamal, M., Eldebeiky, M., Amer, H., Akeel, S., Morsy, A., Amin, A., Shafik, A., Abaza, S., Kaló, Z. (2022). A multi-criteria decision analysis (MCDA) tool for purchasing off-patent oncology medicines in Egypt. Journal of Pharmaceutical Policy and Practice. doi:10.1186/s40545-022-00414-2 Link
Farkas-Ráduly, Sz., Csanádi, M., Ágh, T., Szász, O.,Vokó, Z., Széles, Gy. (2022). A digitális technológia kínálta új lehetőségek a melanoma malignum szűrésében. Szakirodalmi áttekintés [New opportunities offered by digital technology in melanoma malignum screening.]. Orvosi Hetilap. doi: 10.1556/650.2022.32613 Link
Fasseeh, A. N., Elezbawy, B., Adly, W., ElShahawy, R., George, M., Abaza, S., ElShalakani, A., Kaló, Z. (2022). Healthcare financing in Egypt: a systematic literature review. Journal of the Egyptian Public Health Association. doi: 10.1186/s42506-021-00089-8 Link
Fasseeh, A. N., Elezbawy, B., Gamal, M., Seyam, A., Abourawash, A., George, M., Anwar, M., Amin, M., Khalifa, A. Y., Elshalakani, A., Hatem, A., Abdelhamid, S., Elsamouly, H., Fasseeh, N., Adel, R., Dawood, H., Abaza, S., Kaló, Z. (2022). A roadmap toward implementing health technology assessment in Egypt. Frontiers in Public Health. doi: 10.3389/fpubh.2022.896175 Link
Fasseeh, A.N., Elezbawy, B., Korra, N., Tannira, M., Dalle, H., Aderian, S., Abaza, S., Kaló, Z. (2022). Burden of Atopic Dermatitis in Adults and Adolescents: a Systematic Literature Review. Dermatology and Therapy. doi: 10.1007/s13555-022-00819-6 Link
Fasseeh, A. N., Saragih, S. M., Hayek, N., Brodovska, S., Ismail, ElShalakani, A. A., Abaza, S., Obeng, G. D., Ameyaw, D., Kalo, Z. (2022). Impact of Health Technology Assessment Implementation with Special Focus on Middle-Income Countries. Health Policy and Technology. doi: 10.1016/j.hlpt.2022.100688 Link
Gervai, N., Szécsényi-Nagy, B., Zemplényi, A., Csanádi, M., Kollányi, Zs. (2022). A társadalom járványkezelési intézkedésekkel kapcsolatos adherenciájának rendszerszemléletű vizsgálata (Adherence towards public health interventions during the COVID-19 pandemic - lessons from system dynamics). Népegészségügy. Link
Incze, A., Kaló, Z., Espín, J., Kiss, É., Kessabi, S., Garrison, L.P. (2022). Assessing the Consequences of External Reference Pricing for Global Access to Medicines and Innovation: Economic Analysis and Policy Implications. Frontiers in Pharmacology. doi: 10.3389/fphar.2022.815029 Link
Kamusheva, M., Németh, B., Zemplényi, A., Kaló, Z., Elvidge, J., Dimitrova, M., Pontén, J., Tachkov, K., Mitkova, Z. (2022). Using real-world evidence in healthcare from Western to Central and Eastern Europe: a review of existing barriers. Journal of Comparative Effectiveness Research. doi: 10.2217/cer-2022-0065 Link
Kardas, P., Bago, M., Barnestein-Fonseca, P., Garuolienė, K., Granas, A. G., Gregório, J., Hadžiabdić, M. O., Kostalova, B., Leiva-Fernández, F., Lewek, P., Mala-Ladova, K., Schneider, M. P., van Boven, J. F. M., Volmer, D., Ziampara, I., Ágh, T. (2022). Reimbursed medication adherence enhancing interventions in 12 European countries: Current state of the art and future challenges. Frontiers in Pharmacology. doi: 10.3389/fphar.2022.944829 Link
Khanyk, N., Hromovyk, B., Levytska, O., Agh, T., Wettermark, B., Kardas, P. (2022). The impact of the war on maintenance of long-term therapies in Ukraine. Frontiers in Pharmacology. doi: 10.3389/fphar.2022.1024046 Link
Kiss, Z., Wittmann, I., Polivka, L., Surján, Gy., Surján, O., Barcza, Zs., Molnár, G. A., Nagy, D., Müller, V., Bogos, K., Nagy, P., Kenessey, I., Wéber, A., Pálosi, M., Szlávik, J., Schaff, Zs., Szekanecz, Z., Müller, C., Kásler, M., Vokó, Z. (2022). Nationwide Effectiveness of First and Second SARS-CoV2 Booster Vaccines During the Delta and Omicron Pandemic Waves in Hungary (HUN-VE 2 Study). Frontiers in Immunology. doi: 10.3389/fimmu.2022.905585 Link
Koleva-Kolarova, R., Buchanan, J., Vellekoop, H., Huygens, S., Versteegh, M., Rutten-van Mölken, M., Szilberhorn, L., Zelei, T., Nagy, B., Wordsworth, S., Tsiachristas, A. (2022). Financing and Reimbursement Models for Personalised Medicine: A Systematic Review to Identify Current Models and Future Options. Applied Health Economics and Health Policy. doi: 10.1007/s40258-021-00714-9 Link
, , , , , , , , , , (2022). Implementation of coverage with evidence development schemes for medical devices: A decision tool for late technology adopter countries. Health Economics doi: 10.1002/hec.4504 Link
Kovács, S., Németh, B., Erdősi, D., Brodszky, V., Boncz, I., Kaló, Z. and Zemplényi, A., (2022). Should Hungary Pay More for a QALY Gain than Higher-Income Western European Countries?. Applied Health Economics and Health Policy. doi:10.1007/s40258-021-00710-z Link
Lorenzovici, L., Bârzan-Székely, A., Farkas-Ráduly, Sz., Pana, B.C., Csanádi, M., Chiriac, N.D., Kaló, Z. (2022). Burden of Chronic Heart Failure in Romania. Healthcare. doi: 10.3390/healthcare10010107 Link
Main, B., Csanádi, M., Ozieranski, P. (2022). Pricing strategies, executive committee power and negotiation leverage in New Zealand's containment of public spending on pharmaceuticals. Health Economics, Policy & Law. doi: 10.1017/S1744133122000068 Link
Mayer, B., Tóth, M., Csanádi, M., Zemplényi, A., Fadgyas-Freyler, P., Oross-Bécsi, R., Elek, P., Szécsényi-Nagy, B. (2022). A COVID-19 világjárvány hatása a daganatos betegek ellátására (The impact of the COVID-19 pandemic on cancer care). Népegészségügy. Link
Németh, B., Csanádi, M., Inotai, A., Ameyaw, D., Kaló, Z. (2022). Access to high-priced medicines in lower-income countries in the WHO European Region. World Health Organization. Regional Office for Europe. License: CC BY-NC-SA 3.0 IGO Link
Pitter, J. G., Moizs, M., Somogyiné Ezer, É., Lukács, G., Szigeti, A., Repa, I., Csanádi, M., Rutten-van Mölken, M. P. M. H., Islam, K., Kaló, Z., Vokó, Z. (2022). Improved survival of non-small cell lung cancer patients after introducing patient navigation: A retrospective cohort study with propensity score weighted historic control. PLOS ONE. doi: 10.1371/journal.pone.0276719 Link
Sinkovits, B., Kovács-Borbás, V., Lovas, K., Merész, G., Rózsa, P., Salfer, B., & Kaló, Z. (2022). A társadalombiztosítási támogatásra irányuló kérelmek egészség-gazdaságtani elemzéseinek transzparenciakódexe. Lege Artis Medicinae. doi: 10.33616/lam.32.025 Link
Tachkov, K.T., Zemplényi, A., Kamusheva, M.S., Dimitrova, M.J., Siirtola, P., Pontén, J., Nemeth, B., Kaló, Z. and Petrova, G.I. (2022). Barriers to use Artificial Intelligence methodologies in Health Technology Assessment in Central and East European countries. Frontiers in Public Health. doi: 10.3389/fpubh.2022.921226 Link
Tittmann, J., Csanádi, M., Ágh, T., Széles, Gy., Vokó, Z., Ormándi, K., Kallai, Á. (2022). Az automatizált emlőultrahang-daganatszűrés szakirodalmi áttekintése. Orvosi Hetilap. doi: 10.1556/650.2022.32565 Link
Vellekoop, H., Versteegh, M., Huygens, S., Ramos, I. C., Szilberhorn, L., Zelei, T., Nagy, B.,Tsiachristas, A., Koleva-Kolarova, R., Wordsworth, S., Rutten-van Mölken, M. (2022). The Net Benefit of Personalized Medicine: A Systematic Literature Review and Regression Analysis. Value in Health. doi: 10.1016/j.jval.2022.01.006 Link
Vokó, Z., Kiss, Z., Surján, Gy., Surján, O., Barcza, Zs., Wittmann, I., Molnár, G. A., Nagy, D., Müller, V., Bogos, K., Nagy, P., Kenessey, I., Wéber, A., Polivka, L., Pálosi, M., Szlávik, J., Rokszin, Gy., Müller, C., Szekanecz, Z., Kásler, M. (2022). Effectiveness and Waning of Protection With Different SARS-CoV-2 Primary and Booster Vaccines During the Delta Pandemic Wave in 2021 in Hungary (HUN-VE 3 Study). Frontiers in Immunology. doi: 10.3389/fimmu.2022.919408 Link
2021
Aboulghate, M., Elaghoury, A., Elebrashy, I., Elkafrawy, N., Elshishiney, G., Abul-Magd, E., Bassiouny, E., Toaima, D., Elezbawy, B., Fasseeh, A., Abaza, S., Vokó, Z. (2021). The Burden of Obesity in Egypt. Frontiers In Public Health. doi: 10.3389/fpubh.2021.718978 Link
Ádám, I., Kaló, Z. (2021). Development of public financing initiatives in pharmaceutical R&D – is it the key to the future of medicine? Kaleidoscope. doi: 10.17107/KH.2021.22.316-324 Link
Agh, T., van Boven, J.F.M., Wettermark, B., Menditto, E., Pinnock, H., Tsiligianni, I., Petrova, G., Potocnjak, I., Kamberi, F., Kardas, P. (2021). A Cross-Sectional Survey on Medication Management Practices for Noncommunicable Diseases in Europe During the Second Wave of the COVID-19 Pandemic. Frontiers in Pharmacology I Drugs Outcomes Research and Policies. doi: 10.3389/fphar.2021685696 Link
Almomani, E., Alabbadi, I., Fasseeh, A., Al-Qutob, R., Al-Sharu, E., Hayek, N., Tarawneh, M.R., Kaló, Z. (2021). Implementation Road Map of Health Technology Assessment in Middle-Income Countries: The Case of Jordan. Value in Health Regional Issues. doi: 10.1016/j.vhri.2021.01.003 Link
Babela, R., Orsagh, A., Ricova, J., Lansdorp-Vogelaar, I., Csanádi, M., De Koning, H., Reckova, M. (2021). Cost-effectiveness of colorectal cancer screening in Slovakia. European Journal of Cancer Prevention. doi: 10.1097/CEJ.0000000000000727 Link
Blankart, C. R., Dams, F., Penton, H., Kaló, Z., Zemplényi, A., Shatrov, K., Iskandar, R., Federici, C. (2021). Regulatory and HTA early dialogues in medical devices. Health Policy. doi: 10.1016/j.healthpol.2021.07.010 Link
Ciani, O., Grigore, B., Blommestein, H., de Groot, S., Möllenkamp, M., Rabbe, S., Daubner-Bendes, R., Taylor, R. S. (2021). Validity of Surrogate Endpoints and Their Impact on Coverage Recommendations: A Retrospective Analysis across International Health Technology Agencies. Medical Decision Making. doi: 10.1177/0272989X21994553 Link
Daubner-Bendes, R., Kovács, S., Niewada, M., Huic, M., Drummond, M., Ciani, O., Blankart, C.R., Mandrik, O., Torbica, A., Yfantopoulos, J., Petrova, G., Holownia-Voloskova, M., Taylor, R.S., Al, M., Piniazhko, O., Lorenzovici, L., Tarricone, R., Zemplényi, A., Kaló, Z. (2021). Quo Vadis HTA for Medical Devices in Central and Eastern Europe? Recommendations to Address Methodological Challenges. Frontiers in Public Health 8:612410. doi: 10.3389/fpubh.2020.612410 Link
Elvidge, J., Summerfield, A., Knies, S., Németh, B., Kaló, Z., Goettsch, W., Dawoud, D. (2021). Best-practice guidance for the health technology assessment of diagnostics and treatments for COVID-19. doi: 10.5281/zenodo.5530468 Link
Farghaly, M. N., Al Dallal, S., Fasseeh, A. N., Monsef, N. A., Suliman, E. A. M. A., Tahoun, M. A., Abaza, S., Kaló, Z. (2021). Recommendation for a Pilot MCDA Tool to Support the Value-Based Purchasing of Generic Medicines in the UAE. Frontiers in Pharmacology. doi: 10.3389/fphar.2021.680737 Link
Federici, C., Reckers-Droog, V., Ciani, O. Dams, F., Grigore, B., Kaló, Z., Kovács, S., Shatrov, K., Brouwer, W., Drummond, M. (2021). Coverage with evidence development schemes for medical devices in Europe: characteristics and challenges. The European Journal of Health Economics. doi: 10.1007/s10198-021-01334-9 Link
Gálffy, G., Vastag, A., Bogos, K., Kiss, Z., Ostoros, G., Müller, V., Urbán, L., Bittner, N., Sárosi, V., Polányi, Z., Nagy-Erdei, Z., Daniel, A., Knollmajer, K., Várnai, M., Szegner, P., Vokó, Z., Nagy, B., Horváth, K., Rokszin, G., Abonyi-Tóth, Z., Pozsgai, É., Barcza, Z., Moldvay, J., Tamási. L. (2021). Significant Regional Differences in Lung Cancer Incidence in Hungary: Epidemiological Study Between 2011 and 2016. Pathology and Oncology Research. doi: 10.3389/pore.2021.1609916 Link
Gini, A., Buskermolen, M., Senore, C., Anttila, A., Novak Mlakar, D., Veerus, P., Csanádi, M., Jansen, E. E. L., Zielonke, N., Heinävaara, S., Széles, G., Segnan, N., de Koning, H. J., & Lansdorp-Vogelaar, I. (2021). Development and Validation of Three Regional Microsimulation Models for Predicting Colorectal Cancer Screening Benefits in Europe. MDM Policy & Practice. doi:10.1177/2381468320984974 Link
Gini, A., van Ravesteyn, N. T., Jansen, E. E. L., Heijnsdijk, E. A. M., Senore, C., Anttila, A., Mlakar, D. N., Veerus, P., Csanádi, M., Zielonke, N., Heinävaara, S., Széles, Gy., Segnan, N., de Koning, H. J., Lansdorp-Vogelaar, I. (2021). The EU-TOPIA Evaluation Tool: An Online Modelling--Based Tool for Informing Breast, Cervical, and Colorectal Cancer Screening Decisions in Europe. Preventive Medicine Reports. doi: 10.1016/j.pmedr.2021.101392 Link
Godman, B., Wladysiuk, M., McTaggart, S., Kurdi, A., Allocati, E., Jakovljevic, M., Kalemeera, F., Hoxha, I., Nachtnebel, A., Sauermann, R., Hinteregger, M., Marković-Peković, V., Tubic, B., Petrova, G., Tachkov, K., Slabý, J., Nejezchlebova, R., Krulichová, I. S. , Laius, O., Selke, G., Langner, I., Harsanyi, A., Inotai, A., Jakupi, A., Henkuzens, S., Garuolienė, K., Gulbinovič, J., Bonanno, P. V., Rutkowski, J., Ingeberg, S., Melien, Ø., Mardare, I., Fürst, J., MacBride-Stewart, S., Holmes, C., Pontes, C., Zara, C., Pedrola, M. T., Hoffmann, M., Kourafalos, V., Pisana, A., Banzi, R., Campbell, S., Wettermark, B. (2023). Utilisation Trend of Long-Acting Insulin Analogues including Biosimilars across Europe: Findings and Implications. BioMed Research International. doi: 10.1155/2021/9996193 Link
Inotai, A., Ágh, T., Maris, R., Erdősi, D., Kovács, S., Kaló, Z., Senkus, E. (2021). Systematic review of real-world studies evaluating the impact of medication non-adherence to endocrine therapies on hard clinical endpoints in patients with non-metastatic breast cancer. Cancer Treatment Reviews. doi: 10.1016/j.ctrv.2021.102264 Link
Inotai, A., Jakab, I., Brixner, D., Campbell, J., Hawkins, N., Kristensen, L., Charokopou, M., Mountian, I., Szegvari, B., Kaló, Z. (2021). Proposal for Capturing Patient Experience through Extended Value Frameworks of Health Technologies. Journal of Managed Care & Specialty Pharmacy. doi: 10.18553/jmcp.2021.27.7.936 Link
Jakab, I., Whittington, M.D., Franklin, E., Raiola S., Campbell J. D., Kaló, Z., McQueen R. B. (2021). Patient and Payer Preferences for Additional Value Criteria. Frontiers in Pharmacology. doi: 10.3389/fphar.2021.690021 Link
Kaló, Z., Németh, B., Zemplényi, A. (2021). Can cost–effectiveness principles be ignored in urgent times?. Journal of Comparative Effectiveness Research. doi: 10.2217/cer-2021-0211 Link
Kaló, Z., Petykó, Zs.I., Fricke, F-U., Maniadakis, N., Tesař, T., Podrazilová, K., Espin, J., Inotai, A. (2021). Development of a core evaluation framework of value-added medicines: report 2 on pharmaceutical policy perspectives. Cost Effectiveness and Resource Allocation. doi: 10.1186/s12962-021-00296-2 Link
Kardas, P., van Boven, J. F. M., Pinnock, H., Menditto, E., Wettermark, B., Tsiligianni, I., Ágh, T., ENABLE collaborators (2021). Disparities in European Healthcare System Approaches to Maintaining Continuity of Medication for Non-Communicable Diseases During the COVID-19 Outbreak. The Lancet Regional Health - Europe. doi: 10.1016/j.lanepe.2021.100099 Link
Kiss, Z., Bogos, K., Tamási, L., Ostoros, G., Müller, V., Urbán, L., Bittner, N., Sárosi, V., Vastag, A., Polányi, Z., Nagy-Erdei, Z., Knollmajer, K., Várnai, M., Nagy, B., Horváth, K., Rokszin, G., Abonyi-Tóth, Z., Barcza, Z., Moldvay, J., Gálffy, G.,Vokó, Z. (2021). Increase in the Length of Lung Cancer Patient Pathway Before First-Line Therapy: A 6-Year Nationwide Analysis From Hungary. Pathology and Oncology Research doi: 10.3389/pore.2021.1610041 Link
Liszkay, G., Kiss, Z., Gyulai, R., Oláh, J., Holló, P., Emri, G., Csejtei, A., Kenessey, I., Benedek, A., Polányi, Z., Nagy-Erdei, Zs., Daniell, A., Knollmajer, K., Várnai, M., Vokó, Z., Nagy, B., Rokszin, Gy., Fábián, I., Barcza, Zs., Polgár, Cs. (2021). Changing Trends in Melanoma Incidence and Decreasing Melanoma Mortality in Hungary Between 2011 and 2019: A Nationwide Epidemiological Study. Frontiers in Oncology. doi: 10.3389/fonc.2020.612459 Link
Looman, W., Struckmann, V., Köppen, J., Baltaxe, E., Czypionka, T., Huic, M., Pitter, J., Ruths, S., Stokes, J., Bal, R., Rutten-van-Mölken, M. (2021). Drivers of Successful Implementation of Integrated Care for Multi-Morbidity: Mechanisms Identified in 17 Case Studies from 8 European Countries. Social Science & Medicine. doi: 10.1016/j.socsimed.2021.113728 Link
Méroc, E., Fröberg, J., Almási, T., Winje, B. A., Orrico-Sánchez, A., Steens, A., McDonald, S. A., Bollaerts, K., Knol, M. A. (2021). European Data Sources for Computing Burden of (Potential) Vaccine-Preventable Diseases in Aging Adults. BMC Infectious Diseases. doi: 10.1186/s12879-021-06017-7 Link
Nagy, B., Szilberhorn, L., Kerpel-Fronius, A., Moizs, M., Bajzik, G., Vokó, Z. (2021). The Budget Impact of Lung Cancer Screening With Low-Dose Computed Tomography. Orvosi Hetilap. doi: 10.1556/650.2021.32095 Link
Országh, E., Jóźwiak, Á., Süth, M., Micsinai, A., Urbányi, B., Vokó, Z., Kaló, Z., Pitter, J. Gy. (2021). Az egészségügyi technológiaértékelés és kockázat-haszon elemzés alkalmazási lehetőségei az élelmiszerlánc-biztonság területén. Magyar Állatorvosok Lapja. Link
Ozieranski, P., Pitter, J.G., Rickard. E., Mulinari, S., Csanadi, M. (2021). A ‘patient–industry complex’? Investigating the financial dependency of UK patient organisations on drug company funding. Sociology of Health & Illness. doi: 10.1111/1467-9566.13409 Link
Petykó, Zs.I., Kaló, Z., Espin, J., Podrazilová, K., Tesař, T., Maniadakis, N., Fricke, F-U., Inotai, A. (2021). Development of a core evaluation framework of value-added medicines: report 1 on methodology and findings. Cost Effectiveness and Resource Allocation. doi: 10.1186/s12962-021-00311-6 Link
Pogány, G., Csanádi, M., Bódy, É., Bojtor, Zs., Kereki, J., Fadgyas-Freyler, P., Szabó, L., Kaló, Z. (2021). Bizonyítékokon alapuló egészségpolitikai döntéshozatal az integrált ellátásban - A Ritka Betegségek Nemzeti Erőforrás Központjának tervezési folyamata. Orvosi Hetilap. doi: 10.1556/650.2021.32244 Link
Pongiglione, B., Torbica, A., Blommestein, H., De Groot, S., Ciani, O., Walker, S., Dams, F., Blankart, R., Mollenkamp, M., Kovács, S., Tarricone, R., Drummond, M. (2021). Do existing real-world data sources generate suitable evidence for the HTA of medical devices in Europe? Mapping and critical appraisal. International Journal of Technology Assessment in Health Care. doi:10.1017/S0266462321000301 Link
Sarri, G., Freitag, A., Szegvari, B., Mountain, I., Brixner, D., Bertelsen, N., Kaló, Z., Upadhyaya, S. (2021). The Role of Patient Experience In the Value Assessment of Complex Technologies - Do HTA Bodies Need to Reconsider How Value Is Assessed? Health Policy. doi: 10.1016/j.healthpol.2021.03.006 Link
Thomsen, S. T., Assunção, R., Alfonso, C., Boué, G., Cardoso, C., Cubadda, F., Garre, A., Kruisselbrink, J. W., Mantovani, A., Pitter, J. G., Poulsen, M., Verhagen, H., Ververis, E., van der Voet, H., Watzl, B., Pires, S. M. (2021). Human Health Risk-Benefit Assessment of Fish and Other Seafood: A Scoping Review. Critical Reviews in Food Science and Nutrition. doi: 10.1080/10408398.2021.1915240 Link
van Boven, J. F. M., Tsiligianni, I., Potočnjak. I., Mihajlović, J., Dima, A. L., Nabergoj, M. U., Ágh, T., Kardas, P., Ghiciuc, C. M., Petrova, G., Bitterman, N., Kamberi, F., Culig, J., Wettermark, B. (2022). European Network to Advance Best Practices and Technology on Medication Adherence: Mission Statement. Frontiers in Pharmacology. doi: 10.3389/fphar.2021.748702 Link
Vellekoop, H. Huygens, S., Versteegh, M., Szilberhorn, L., Zelei, T., Nagy, B., Koleva-Kolarova, R., Tschiachristas, A., Wordsworth, S., Rutten-van Mölken, M. (2021). Guidance For The Harmonisation and Improvement of Economic Evaluations of Personalised Medicine. PharmacoEconomics. doi: 10.1007/s40273-021-01010-z Link
Vokó, Z., Kiss, Z., Surján, Gy., Surján, O., Barcza, Zs., Pályi, B., Formanek-Balku, E., Molnár, G. A., Herczeg, R., Gyenesei, A., Miseta, A., Kollár, L., Wittmann, I., Müller, C., Kásler, M. (2021). Nationwide effectiveness of five SARS-CoV-2 vaccines in Hungary - The HUN-VE study. Clinical Microbiology and Infection. doi: 10.1016/j.cmi.2021.11.011 Link
Zelei, T., Mendola, N. D., Elezbawy, B., Németh, B., Campbell, J. D. (2021). Criteria and Scoring Functions in Multi-criteria Decision Analysis and Value Frameworks for the Assessment of Rare Disease Therapies: A Systematic Literature Review. PharmacoEconomics - Open. doi: 10.1007/s41669-021-00271-w Link
Zemplényi, A. T., Csikós, Á., Fadgyas-Freyler, P., Csanádi, M., Kaló, Z., Pozsgai, É., Rutten-van Mölken, M., Pitter, J. Gy. (2021). Early Palliative Care Associated with Lower Costs for Adults with Advanced Cancer: Evidence From Hungary. European Journal of Cancer Care. doi: 10.1111/ecc.13473 Link
2020
Almási, T., Abul-Mad, E., George, M., Arnaiz, F., Elezbawy, B., Nagy, B., Kaló Z. (2020). Supporting Role of Non-Governmental Health Insurance Schemes in The Implementation of Universal Health Coverage in Developing Countries. Journal of Health Policy & Outcomes Research. doi:10.7365/JHPOR.2020.1.4 Link
Bogos, K., Kiss, Z., Gálffy, G., Tamási, L., Ostoros, G., Müller, V., Urbán, L., Bittner, N., Sárosi, V., Vastag, A., Polányi, Z., Nagy-Erdei, Z., Vokó, Z., Nagy, B., Horváth, K., Rokszin, G., Abonyi-Tóth, Z., Barcza, Z., & Moldvay, J. (2020). Lung Cancer in Hungary. Journal of Thoracic Oncology, 15(5), 692-699. doi:10.1016/j.jtho.2019.11.001 Link
Bogos, K., Kiss, Z., Gálffy, G., Tamási, L., Ostoros, G., Müller, V., Urbán, L., Bittner, N., Sárosi, V., Vastag, A., Polányi, Z., Nagy-Erdei, Z., Vokó, Z., Nagy, B., Rokszin, G., Abonyi-Tóth, Z., Moldvay, J. (2020). [Novel approaches to the epidemiology of lung cancer in Hungary]. Magyar Onkológia, 64(3), 175-181. Link
Csanádi, M., Ágh, T., Farkas-Ráduly, S., Gros, B., Tapprich, C., Trudeau, J. J., Lipton, J. H., & Mattsson, J. (2020). Patient-reported Symptom Burden of Chronic Graft Versus Host Disease: A Systematic Literature Review. Expert Review of Hematology. doi: 10.1080/17474086.2020.1818065 Link
Csanádi, M., Gini, A., Koning, H., Széles, G., Pitter, J.G., Oroszi, B., Pataki, P., Fadgyas-Freyler, P., Korponai, G., Vokó, Z., Lansdorp-Vogelaar, I. (2020). Modeling Costs and Benefits of the Organized Colorectal Cancer Screening Programme and Its Potential Future Improvements in Hungary. Journal of Medical Screening. doi:10.1177/0969141320968598 Link
Czypionka, T., Kraus, M., Reiss, M., Baltaxe, E., Roca, J., Ruths, S., Stokes, J., Struckmann, V., Haček, R. T., Zemplényi, A., Hoedemakers, M., & Rutten-van Mölken, M. (2020). The Patient at the Centre: Evidence From 17 European Integrated Care Programmes for Persons with Complex Needs. BMC Health Services Research, 20(1), 1102. doi:10.1186/s12913-020-05917-9 Link
Fasseeh, A.N., Karam, R., Jameleddine, M., George, M., Kristensen, F.B., Al-Rabayah, A., Alsaggabi, A., El Rabbat, M., Alowayesh, M., Chamova, J., Ismail, A. (2020). Implementation of Health Technology Assessment in the Middle East and North Africa: Comparison Between the Current and Preferred Status. Frontiers in Pharmacology, 11, 15. doi: 10.3389/fphar.2020.00015 Link
Grigore, B., Ciani, O., Dams, F., Federici, C., de Groot, S., Möllenkamp, M., Rabbe, S., Shatrov, K., Zemplenyi, A., & Taylor, R. S. (2020). Surrogate Endpoints in Health Technology Assessment: An International Review of Methodological Guidelines. PharmacoEconomics. doi:10.1007/s40273-020-00935-1 Link
Haluzík, M., Flekač, M., Lengyel, C., Taybani, Z., Guja, C., Mihai, B.-M., Cerghizan, A., Martinka, E., Kovacs, G., & Kempler, P. (2020). Expert Opinion on the Therapeutic Use of the Fixed-Ratio Combination of Insulin Glargine 100 U/mL and Lixisenatide: a Central/Eastern European Perspective. Diabetes Therapy, 11(4), 1029-1043. doi:10.1007/s13300-020-00777-2 Link
Inotai, A., Tomek, D., Niewada, M., Lorenzovici, L., Kolek, M., Weber, J., Kurrat, A., Kiss, E., Kalo, Z. (2020). Identifying Patient Access Barriers for Tumor Necrosis Factor Alpha Inhibitor Treatments in Rheumatoid Arthritis in Five Central Eastern European Countries. Frontiers in Pharmacology. 11: 845. doi: 10.3389/fphar. Link
Jakab, I., Németh, B., Elezbawy, B., Karadayı, M.A., Tozan, H., Aydın, S., Shen, J., Kaló, Z. (2020). Potential Criteria for Frameworks to Support the Evaluation of Innovative Medicines in Upper-Middle-Income Countries-A Systematic Literature Review on Value Frameworks and Multi-Criteria Decision Analyses. Frontiers in Pharmacology, 11, 1203. doi: 10.3389/fphar.2020.01203 Link
Kaló, Z., Zemplényi, A., Rutten-Van Molken, M., Looman, W., Huić, M., & Tandara, R. (2020). Development of Transferability Guidance for Integrated Care Models with Special Focus on Central and Eastern European countries. Croatian Medical Journal, 61(3), 252. doi: 10.3325/cmj.2020.61.252 Link
Kovács, G., Devercelli, G., Zelei, T., Hirji, I., Vokó, Z., Keown, P. A. (2020). Association Between Transplant Glomerulopathy and Graft Outcomes Following Kidney Transplantation: A Meta-Analysis. PLOS ONE, 15(4), e0231646. doi:10.1371/journal.pone.0231646 Link
Merkely, B., Szabó, A. J., Kosztin, A., Berényi, E., Sebestyén, A., Lengyel, C., Merkely, G., Karády, J., Várkonyi, I., Papp, C., Miseta, A., Betlehem, J., Burián, K., Csóka, I., Vásárhelyi, B., Ludwig, E., Prinz, G., Sinkó, J., Hankó, B., Varga, P., Fülöp, G., Mag, K., & Vokó, Z. (2020). Novel Coronavirus Epidemic in the Hungarian Population, A Cross-Sectional Nationwide Survey to Support the Exit policy in Hungary. GeroScience, 1-12. doi:10.1007/s11357-020-00226-9 Link
Németh, B., Goettsch, W., Kristensen, F. B., Pinyazhko, O., Huić, M., Tesař, T., Atanasijevic, D., Lipska, I., & Kaló, Z. (2020). The Transferability of Health Technology Assessment - the European Perspective with Focus on Central and Eastern European Countries. Expert Review of Pharmacoeconomic Outcomes Research. doi:10.1080/14737167.2020.1779061 Link
Németh, B., Kaló, Z. (2020). European Cooperation in Health Technology Assessment Implementation: The Perspective of Central and Eastern European Countries. Journal of Comparative Effectiveness Research. doi: 10.2217/cer-2020-0062 Link
Országh, E., Pitter, J. G., Kaló, Z., Vokó, Z., Józwiak, Á. (2020). Retrospective Cost-Utility Analysis of The Non-Typhoidal Salmonella Control Programme in Hungary. Food Control. doi: 10.1016/j.foodcont.2020.107529. Link
Ozieranski, P., Csanádi, M., Rickard, E., Mulinari, E. (2020). Under-Reported Relationship: A Comparative Study of Pharmaceutical Industry and Patient Organisation Payment Disclosures in the UK (2012–2016). BMJ Open. 2020 Sep 19;10(9):e037351. doi: 10.1136/bmjopen-2020-037351. Link
Petykó, Z. I., Inotai, A., Holtorf, A.-P., Brixner, D., Kaló, Z. (2020). Barriers and facilitators of exploiting the potential of value-added medicines. Expert Review of Pharmacoeconomics & Outcomes Research doi: 10.1080/14737167.2020.1758558 Link
Rais, C., Kaló, Z., Csanádi, M., Negulescu, V. (2020). Current and future perspectives for the implementation of health technology assessment in Romania. Health Policy and Technology, 9(1), 45-52. doi: 10.1016/j.hlpt.2019.11.007 Link
Rutten-van Mölken, M., Karimi, M., Leijten, F., Hoedemakers, M., Looman, W., Islam, K., Askildsen, J. E., Kraus, M., Ercevic, D., Struckmann, V., Gyorgy Pitter, J., Cano, I., Stokes, J., Jonker, M. (2020). Comparing patients’ and other stakeholders’ preferences for outcomes of integrated care for multimorbidity: a discrete choice experiment in eight European countries. BMJ Open, 10(10), e037547. doi:10.1136/bmjopen-2020-037547 Link
Vokó, Z., Pitter, J. G. (2020). The effect of social distance measures on COVID-19 epidemics in Europe: an interrupted time series analysis. GeroScience, 1–8. Advance online publication. https://doi.org/10.1007/s11357-020-00205-0 Link
Vokó, Z., Bitter, I., Mersich, B., Réthelyi, J., Molnár, A., Pitter, J. G., Götze, Á., Horváth, M., Kóczián, K., Fonticoli, L., Lelli, F., Németh, B. (2020). Using informative prior based on expert opinion in Bayesian estimation of the transition probability matrix in Markov modelling—an example from the cost-effectiveness analysis of the treatment of patients with predominantly negative symptoms of schizophrenia with cariprazine. Cost Effectiveness and Resource Allocation, 18(1), 28. doi:10.1186/s12962-020-00224-w Link
Zemplényi, A. T., Csikós, Á., Csanádi, M., Mölken, M. R.-v., Hernandez, C., Pitter, J. G., Czypionka, T., Kraus, M., & Kaló, Z. (2020). Implementation of palliative care consult Service in Hungary – integration barriers and facilitators. BMC Palliative Care, 19(1). doi:10.1186/s12904-020-00541-0 Link
Zemplényi, A. T., Csikós, Á., Fadgyas-Freyler, P., Csanádi, M., Kaló, Z., Pozsgai, É., Rutten-van Mölken, M., & Pitter, J. G. (2020). Care Integration Decreases Hospitalization Costs: Retrospective Cohort Study of Palliative Care Consult Service for Hospital Patients With Metastatic Cancer. doi:10.21203/rs.3.rs-41113/v1 Link
2019
Abdullah, A. H., Holtorf, A.-P., Al-Hussaini, M., Lemay, J., Alowayesh, M., Kaló, Z. (2019). Stakeholder driven development of a multi-criteria decision analysis tool for purchasing off-patent pharmaceuticals in Kuwait. Journal of Pharmaceutical Policy and Practice, 12, 9-9. doi: 10.1186/s40545-019-0171-4 Link
Agh, T., Csanadi, M., Voko, Z., Webb, T., Jeyakumaran, D., Trudeau, J., Sengupta, N., Schain, F., Mattsson, J. (2019). Humanistic burden of patients with chronic graft-versus-host disease-systematic literature review of health-related quality of life and functional status. Expert Review of Hematology, 12(5), 295-309. doi: 10.1080/17474086.2019.1602036 Link
Almási, T., Guey, L. T., Lukacs, C., Csetneki, K., Vokó, Z., Zelei, T. (2019). Systematic literature review and meta-analysis on the epidemiology of propionic acidemia. Orphanet Journal of Rare Diseases, 14(1). doi: 10.1186/s13023-018-0987-z Link
Almási, T., Guey, L. T., Lukacs, C., Csetneki, K., Vokó, Z., Zelei, T. (2019). Systematic literature review and meta-analysis on the epidemiology of methylmalonic acidemia (MMA) with a focus on MMA caused by methylmalonyl-CoA mutase (mut) deficiency. Orphanet Journal of Rare Diseases, 14(1). doi: 10.1186/s13023-019-1063-z Link
Baltaxe, E., Czypionka, T., Kraus, M., Reiss, M., Askildsen, J. E., Grenkovic, R., Lindén, T. S., Pitter, J. G., Rutten-van Molken, M., Solans, O., Stokes, J., Struckmann, V., Roca, J., Cano, I. (2019). Digital Health Transformation of Integrated Care in Europe: Overarching Analysis of 17 Integrated Care Programs. Journal of Medical Internet Research, 21(9), e14956. doi: 10.2196/14956 Link
Bendes, R., Németh, B., Pitter, J.G., Kóczián, K., Götze, Á., Kaló, Z. (2019). Magyarországon becsült életminőséggel korrigált életévnyereség lehetősége a negatív tünetes szkizofréniában kariprazin alkalmazása esetén. LAM. 2019. 29(10). 467-475. Link
Bogos, K., Kiss, Z., Gálffy, G., Tamási, L., Ostoros, G., Müller, V., Urbán, L., Bittner, N., Sárosi, V., Vastag, A., Polányi, Z., Nagy-Erdei, Z., Vokó, Z., Nagy, B., Horváth, K., Rokszin, G., Abonyi-Tóth, Z., Moldvay, J. (2019). Revising Incidence and Mortality of Lung Cancer in Central Europe: An Epidemiology Review From Hungary. Frontiers in Oncology, 9. doi: 10.3389/fonc.2019.01051 Link
Csanadi, M., Agh, T., Tordai, A., Webb, T., Jeyakumaran, D., Sengupta, N., Schain, F., Mattsson, J. (2019). A systematic literature review of incidence, mortality, and relapse of patients diagnosed with chronic graft versus host disease. Expert Review of Hematology, 12(5), 311-323. doi: 10.1080/17474086.2019.1605288 Link
Csanádi, M., Inotai, A., Oleshchuk, O., Lebega, O., Alexandra, B., Piniazhko, O., Németh, B., Kaló, Z. (2019). Health Technology Assessment Implementation in Ukraine: Current Status and Future Perspectives. International Journal of Technology Assessment in Health Care, 35(5), 393-400. doi: 10.1017/s0266462319000679 Link
Csanádi, M., Löblová, O., Ozierański, P., Harsányi, A., Kaló, Z., McKee, M., King, L. (2018). When health technology assessment is confidential and experts have no power: the case of Hungary. Health Economics, Policy and Law, 14(2), 162-181. doi: 10.1017/s1744133118000051 Link
Csanádi, M., de Kok, I. M. C. M., Heijnsdijk, E. A. M., Anttila, A., Heinävaara, S., Pitter, J. G., Széles, G., Ivanuš, U., Priaulx, J., Veerus, P., Senore, C., Koning, H. J. d., Vokó, Z. (2019). Key indicators of organized cancer screening programs: Results from a Delphi study. Journal of Medical Screening, 26(3), 120-126. doi: 10.1177/0969141318820362 Link
Csanádi, M., Ozierański, P., Löblová, O., King, L., Kaló, Z., Botz, L. (2019). Shedding light on the HTA consultancy market: Insights from Poland. Health Policy, 123(12), 1237-1243. doi: 10.1016/j.healthpol.2019.08.008 Link
Freijer, K., Volger, S., Pitter, J. G., Molsen-David, E., Cooblall, C., Evers, S., Hiligsmann, M., Danel, A., Lenoir-Wijnkoop, I. (2019). Medical Nutrition Terminology and Regulations in the United States and Europe—A Scoping Review: Report of the ISPOR Nutrition Economics Special Interest Group. Value in Health, 22(1), 1-12. doi: 10.1016/j.jval.2018.07.879 Link
Harsányi, A., Csanádi, M., Márky, K., Vincziczki, Á. Z., Kaló, Z., Inotai, A. (2019). Influence of biosimilar infliximab launch on the utilization pattern of biological medicines: the case of Hungary. Expert Review of Pharmacoeconomics & Outcomes Research, 1-7. doi: 10.1080/14737167.2019.1667232 Link
Holtorf, A.-P., Gialama, F., Wijaya, K. E., Kaló, Z. (2019). External Reference Pricing for Pharmaceuticals—A Survey and Literature Review to Describe Best Practices for Countries With Expanding Healthcare Coverage. Value in Health Regional Issues, 19, 122-131. doi: 10.1016/j.vhri.2019.04.003 Link
Inotai, A., Kaló, Z. (2019). How to solve financing gap to ensure patient access to patented pharmaceuticals in CEE countries?–the good, the bad, and the ugly ways. Expert Review of Pharmacoeconomics & Outcomes Research, 19(6), 627-632. doi: 10.1080/14737167.2019.1702524 Link
Kaló, Z., van den Akker, L. H. M., Vokó, Z., Csanádi, M., Pitter, J. G. (2019). Is there a fair allocation of healthcare research funds by the European Union? PLOS ONE, 14(4), e0207046. doi:10.1371/journal.pone.0207046 Link
Lukács, G., Kovács, Á., Csanádi, M., Moizs, M., Repa, I., Kaló, Z., Vokó, Z., Pitter, J. G. (2019). Benefits Of Timely Care In Pancreatic Cancer: A Systematic Review To Navigate Through The Contradictory Evidence. Cancer Management and Research, Volume 11, 9849-9861. doi:10.2147/cmar.s221427.Link
Löblová, O., Csanádi, M., Ozierański, P., Kaló, Z., King, L., McKee, M. (2019). Alternative access schemes for pharmaceuticals in Europe: Towards an emerging typology. Health Policy, 123(7), 630-634. doi: 10.1016/j.healthpol.2019.05.012 Link
Löblová, O., Csanádi, M., Ozierański, P., Kaló, Z., King, L., McKee, M. (2019). Patterns of alternative access: Unpacking the Slovak extraordinary drug reimbursement regime 2012-2016. Health Policy, 123(8), 713-720. doi: 10.1016/j.healthpol.2019.05.021 Link
Nemeth. B. (2019). Possibility of Quality-adjusted Life Year Gain with Cariprazine in Patients with Negative Symptoms of Schizophrenia in Hungary (in Hungarian). Lege Artis Medicinæ - 2019;29(08-09):389–394. doi: 10.33616/lam.29.040 Link
Németh, B., Bendes, R., Nagy, B., Götze, Á., Kóczián, K., Horváth, M., Deák, I., Tóth, B., Kaló, Z. (2019). Cost-utility analysis of cariprazine compared to risperidone among patients with negative symptoms of schizophrenia. Health Policy and Technology, 8(1), 84-91. doi: 10.1016/j.hlpt.2019.01.004 Link
Németh, B., Molnár, A., Bozóki, S., Wijaya, K., Inotai, A., Campbell, J. D., Kaló, Z. (2019). Comparison of weighting methods used in multicriteria decision analysis frameworks in healthcare with focus on low- and middle-income countries. Journal of Comparative Effectiveness Research, 8(4), 195-204. doi: 10.2217/cer-2018-0102 Link
Pednekar, P. P., Ágh, T., Malmenäs, M., Raval, A. D., Bennett, B. M., Borah, B. J., Hutchins, D. S., Manias, E., Williams, A. F., Hiligsmann, M., Turcu-Stiolica, A., Zeber, J. E., Abrahamyan, L., Bunz, T. J., Peterson, A. M. (2019). Methods for Measuring Multiple Medication Adherence: A Systematic Review–Report of the ISPOR Medication Adherence and Persistence Special Interest Group. Value in Health, 22(2), 139-156. doi: 10.1016/j.jval.2018.08.006 Link
Pitter, J. G., Csanádi, M., Szigeti, A., Lukács, G., Kovács, Á., Moizs, M., Repa, I., Zemplényi, A., Czypionka, T., Kraus, M., Rutten-van Mölken, M. P. M. H., Kaló, Z. (2019). Planning, implementation and operation of a personalized patient management system for subjects with first suspect of cancer (OnkoNetwork): system description based on a qualitative study. BMC Health Services Research, 19(1). doi: 10.1186/s12913-019-3957-9 Link
Tesar, T., Obsitnik, B., Kaló, Z., Kristensen, F. B. (2019). How changes in reimbursement practices influence the financial sustainability of medicine policy: lessons learned from Slovakia. Frontiers in Pharmacology, 10, 664. doi: 10.3389/fphar.2019.00664 Link
Szilberhorn, L., Kaló, Z., Ágh, T. (2019). Cost-effectiveness of second-generation direct-acting antiviral agents in chronic HCV infection: a systematic literature review. Antiviral Therapy, 24(4), 247-259. doi: 10.3851/imp3290 Link
Szilberhorn, L., Kőrösi, L., Vajer, P., Nagy, B., Vokó, Z. (2019). Cost-effectiveness of introducing licensed GP practices to manage diabetes patients in Hungary. Primary Care Diabetes, 13(5), 462-467. doi: 10.1016/j.pcd.2019.03.004 Link
2018
Ágh, T., Gáspár, K., Nagy, B., Lehmann, M., Kaló, Z. (2018). The value of a child born in the European Union. Acta Oeconomica, 68(2), 295-309. doi: 10.1556/032.2018.68.2.6 Link
Begum, M., Lewison, G., Jassem, J., Mixich, V., Cufer, T., Nurgozhin, T., Shabalkin, P., Kutluk, T., Voko, Z., Radosavljevic, D., Vrdoljiak, E., Eniu, A., Walewski, J., Aggarwal, A., Lawler, M., Sullivan, R. (2018). Mapping cancer research across Central and Eastern Europe, the Russian Federation and Central Asia: Implications for future national cancer control planning. European Journal of Cancer, 104, 127-136. doi: 10.1016/j.ejca.2018.08.024 Link
Bochenek, T., Abilova, V., Alkan, A., Asanin, B., de Miguel Beriain, I., Besovic, Z., Vella Bonanno, P., Bucsics, A., Davidescu, M., De Weerdt, E., Duborija-Kovacevic, N., Fürst, J., Gaga, M., Gailīte, E., Gulbinovič, J., Gürpınar, E. U., Hankó, B., Hargaden, V., Hotvedt, T. A., Hoxha, I., Huys, I., Inotai, A., Jakupi, A., Jenzer, H., Joppi, R., Laius, O., Lenormand, M.-C., Makridaki, D., Malaj, A., Margus, K., Marković-Peković, V., Miljković, N., de Miranda, J. L., Primožič, S., Rajinac, D., Schwartz, D. G., Šebesta, R., Simoens, S., Slaby, J., Sović-Brkičić, L., Tesar, T., Tzimis, L., Warmińska, E., Godman, B. (2018). Systemic Measures and Legislative and Organizational Frameworks Aimed at Preventing or Mitigating Drug Shortages in 28 European and Western Asian Countries. Frontiers in Pharmacology, 8. doi: 10.3389/fphar.2017.00942 Link
Brixner, D., Kaló, Z., Maniadakis, N., Kim, K., Wijaya, K. (2018). An Evidence Framework for Off-Patent Pharmaceutical Review for Health Technology Assessment in Emerging Markets. Value in Health Regional Issues, 16, 9-13. doi: 10.1016/j.vhri.2018.01.003 Link
Campbell, J. D., Kaló, Z. (2018). Fair global drug pricing. Expert Review of Pharmacoeconomics & Outcomes Research, 18(6), 581-583. doi: 10.1080/14737167.2018.1524296 Link
Csanádi, M., Kaló, Z., Prins, C. P. J., Grélinger, E., Menczelné Kiss, A., Fricke, F.-U., Fuksa, L., Tesar, T., Manova, M., Lorenzovici, L., Vokó, Z., Garrison, L. P. (2018). The implications of external price referencing on pharmaceutical list prices in Europe. Health Policy and Technology, 7(3), 243-250. doi: 10.1016/j.hlpt.2018.07.005 Link
Fasseeh, A., Németh, B., Molnár, A., Fricke, F. U., Horváth, M., Kóczián, K., Götze, Á., Kaló, Z. (2018). A systematic review of the indirect costs of schizophrenia in Europe. European Journal of Public Health, 28(6), 1043-1049. doi: 10.1093/eurpub/cky231 Link
Freijer, K., Volger, S., Pitter, J. G., Molsen-David, E., Cooblall, C., Evers, S., Hiligsmann, M., Danel, A., Lenoir-Wijnkoop, I. (2019). Medical Nutrition Terminology and Regulations in the United States and Europe—A Scoping Review: Report of the ISPOR Nutrition Economics Special Interest Group. Value in Health, 22(1), 1-12. doi: 10.1016/j.jval.2018.07.879 Link
Gyulai, A., Nagy, A., Pataki, V., Tonté, D., Ádány, R., Vokó, Z. (2018). General practitioners can increase participation in cervical cancer screening – a model program in Hungary. BMC Family Practice, 19(1). doi: 10.1186/s12875-018-0755-0 Link
Inotai, A., Ágh, T., Karpenko, A. W., Zemplényi, A., Kaló, Z. (2018). Behind the subcutaneous trastuzumab hype: evaluation of benefits and their transferability to Central Eastern European countries. Expert Review of Pharmacoeconomics & Outcomes Research, 19(2), 105-113. doi: 10.1080/14737167.2019.1554437 Link
Inotai, A., Nguyen, H. T., Hidayat, B., Nurgozhin, T., Kiet, P. H. T., Campbell, J. D., Németh, B., Maniadakis, N., Brixner, D., Wijaya, K., Kaló, Z. (2018). Guidance toward the implementation of multicriteria decision analysis framework in developing countries. Expert Review of Pharmacoeconomics & Outcomes Research, 18(6), 585-592. doi: 10.1080/14737167.2018.1508345 Link
Inotai, A., Csanadi, M., Petrova, G., Dimitrova, M., Bochenek, T., Tesar, T., York, K., Fuksa, L., Kostyuk, A., Lorenzovici, L., Omelyanovskiy, V., Egyed, K., Kalo, Z. (2018). Patient Access, Unmet Medical Need, Expected Benefits, and Concerns Related to the Utilisation of Biosimilars in Eastern European Countries: A Survey of Experts. BioMed Research International, 2018, 1-9. doi: 10.1155/2018/9597362 Link
Inotai, A., Brixner, D., Maniadakis, N., Dwiprahasto, I., Kristin, E., Prabowo, A., Yasmina, A., Priohutomo, S., Németh, B., Wijaya, K., Kalo, Z. (2018). Development of multi-criteria decision analysis (MCDA) framework for off-patent pharmaceuticals - an application on improving tender decision making in Indonesia. BMC health services research, 18(1), 1003-1003. doi: 10.1186/s12913-018-3805-3 Link
Kamusheva, M., Manova, M., Savova, A. T., Petrova, G. I., Mitov, K., Harsányi, A., Kaló, Z., Márky, K., Kawalec, P., Angelovska, B., Lakić, D., Tesar, T., Draganic, P., Geitona, M., Hatzikou, M., Paveliu, M. S., Männik, A. (2018). Comparative Analysis of Legislative Requirements About Patients' Access to Biotechnological Drugs for Rare Diseases in Central and Eastern European Countries. Frontiers in Pharmacology, 9. doi: 10.3389/fphar.2018.00795 Link
Kolasa, K., Zwolinski, K. M., Zah, V., Kaló, Z., Lewandowski, T. (2018). Revealed preferences towards the appraisal of orphan drugs in Poland - multi criteria decision analysis. Orphanet Journal of Rare Diseases, 13(1). doi: 10.1186/s13023-018-0803-9 Link
Kovács, G., Almási, T., Millier, A., Toumi, M., Horváth, M., Kóczián, K., Götze, À., Kaló, Z., Zemplényi, A. T. (2018). Direct healthcare cost of schizophrenia – European overview. European Psychiatry, 48(1), 79-92. doi: 10.1016/j.eurpsy.2017.10.008 Link
Kulchaitanaroaj, P., Kaló, Z., West, R., Cheung, K. L., Evers, S., Vokó, Z., Hiligsmann, M., de Vries, H., Owen, L., Trapero-Bertran, M., Leidl, R., Pokhrel, S. (2018). Understanding perceived availability and importance of tobacco control interventions to inform European adoption of a UK economic model: a cross-sectional study. BMC Health Services Research, 18(1). doi: 10.1186/s12913-018-2923-2 Link
Leijten, F. R. M., Hoedemakers, M., Struckmann, V., Kraus, M., Cheraghi-Sohi, S., Zemplényi, A., Ervik, R., Vallvé, C., Huiĉ, M., Czypionka, T., Boland, M., Rutten-van Mölken, M. P. M. H. (2018). Defining good health and care from the perspective of persons with multimorbidity: results from a qualitative study of focus groups in eight European countries. BMJ Open, 8(8), e021072. doi: 10.1136/bmjopen-2017-021072 Link
Nemeth, B. (2018). Health Economics in Hungary: Great potential, missed opportunity? [in Hungarian]. LEGE ARTIS MEDICINÆ- 28(06-07). Link
Németh, B., Józwiak-Hagymásy, J., Kovács, G., Kovács, A., Demjén, T., Huber, M. B., Cheung, K.-L., Coyle, K., Lester-George, A., Pokhrel, S., Vokó, Z. (2018). Cost-effectiveness of possible future smoking cessation strategies in Hungary: results from the EQUIPTMOD. Addiction, 113, 76-86. doi: 10.1111/add.14089 Link
Németh, B., Fasseeh, A., Molnár, A., Bitter, I., Horváth, M., Kóczián, K., Götze, Á., Nagy, B. (2018). A systematic review of health economic models and utility estimation methods in schizophrenia. Expert Review of Pharmacoeconomics & Outcomes Research, 18(3), 267-275. doi: 10.1080/14737167.2018.1430571 Link
Németh, B., Kulchaitanaroaj, P., Lester-George, A., Huic, M., Coyle, K., Coyle, D., Pokhrel, S., Kaló, Z. (2018). A utility of model input uncertainty analysis in transferring tobacco control-related economic evidence to countries with scarce resources: results from the EQUIPT study. Addiction, 113, 42-51. doi: 10.1111/add.14092 Link
Nestler-Parr, S., Korchagina, D., Toumi, M., Pashos, C. L., Blanchette, C., Molsen, E., Morel, T., Simoens, S., Kaló, Z., Gatermann, R., Redekop, W. (2018). Challenges in Research and Health Technology Assessment of Rare Disease Technologies: Report of the ISPOR Rare Disease Special Interest Group. Value in Health, 21(5), 493-500. doi: 10.1016/j.jval.2018.03.004 Link
Ozierański, P., Löblová, O., Nicholls, N., Csanádi, M., Kaló, Z., McKee, M., King, L. (2018). Transparency in practice: Evidence from ‘verification analyses’ issued by the Polish Agency for Health Technology Assessment in 2012–2015. Health Economics, Policy and Law, 14(2), 182-204. doi: 10.1017/s1744133117000342 Link
Pitter, J. G., Vokó, Z., Józwiak, Á., Berkics, A. (2018). Campylobacter control measures in indoor broiler chicken: critical re-assessment of cost-utility and putative barriers to implementation. Epidemiology and Infection, 146(11), 1433-1444. doi: 10.1017/s0950268818001528 Link
Pitter, J. G., Lukács, G., Csanádi, M., Vokó, Z. (2018). Clinical impact of treatment delay in pancreatic cancer patients revisited. International Journal of Cancer, 142(12), 2621-2622. doi: 10.1002/ijc.31263 Link
Priaulx, J., Csanádi, M., de Koning, H. J., McKee, M. (2018). A choice experiment to identify the most important elements of a successful cancer screening program according to those who research and manage such programs. The International Journal of Health Planning and Management, 34(1), e34-e45. doi: 10.1002/hpm.2697 Link
Priaulx, J., de Koning, H. J., de Kok, I. M. C. M., Széles, G., McKee, M. (2018). Identifying the barriers to effective breast, cervical and colorectal cancer screening in thirty-one European countries using the Barriers to Effective Screening Tool (BEST). Health Policy, 122(11), 1190-1197. doi: 10.1016/j.healthpol.2018.08.004 Link
Rutten- van Molken, M., Leijten, F., Hoedemakers, M., Tsicahristas, A., Verbeek, N., Bal, R., De Bont, A., Islam, K., Askildsen, J.-E., Czypionka, T., Huic, M., Pitter, J., Vogt, V., Stokes, J., Baltaxe, E. (2018). Strengthening the evidence-base of integrated care for people with multi-morbidity in Europe using Multi-Criteria Decision Analyses MCDA. International Journal of Integrated Care, 18(s2), 315. doi: 10.5334/ijic.s2315 Link
Szegedi, M., Zelei, T., Arickx, F., Bucsics, A., Cohn-Zanchetta, E., Fürst, J., Kamusheva, M., Kawalec, P., Petrova, G., Slaby, J., Stawowczyk, E., Vocelka, M., Zechmeister-Koss, I., Kaló, Z., Molnár, M. J. (2018). The European challenges of funding orphan medicinal products. Orphanet Journal of Rare Diseases, 13(1). doi: 10.1186/s13023-018-0927-y Link
Trapero-Bertran, M., Muñoz, C., Coyle, K., Coyle, D., Lester-George, A., Leidl, R., Németh, B., Cheung, K.-L., Pokhrel, S., Lopez-Nicolás, Á. (2018). Cost-effectiveness of alternative smoking cessation scenarios in Spain: results from the EQUIPTMOD. Addiction, 113, 65-75. doi: 10.1111/add.14090 Link
Turnbull, E., Priaulx, J., van Ravesteyn, N. T., Heinävaara, S., Siljander, I., Senore, C., Segnan, N., Vokó, Z., Hagymásy, J., Jarm, K., Veerus, P., de Koning, H. J., McKee, M. (2018). A health systems approach to identifying barriers to breast cancer screening programmes. Methodology and application in six European countries. Health Policy, 122(11), 1198-1205. doi: 10.1016/j.healthpol.2018.08.003 Link
Turnbull, E., Priaulx, J., de Kok, I. M. C. M., Lansdorp-Vogelaar, I., Anttila, A., Sarkeala, T., Senore, C., Segnan, N., Csanádi, M., Pitter, J., Novak Mlakar, D., Ivanus, U., Veerus, P., de Koning, H. J., McKee, M. (2018). Results of a health systems approach to identify barriers to population-based cervical and colorectal cancer screening programmes in six European countries. Health Policy, 122(11), 1206-1211. doi: 10.1016/j.healthpol.2018.08.005 Link
Zelei, T., Csetneki, K., Vokó, Z., Siffel, C. (2018). Epidemiology of Sanfilippo syndrome: results of a systematic literature review. Orphanet Journal of Rare Diseases, 13(1). doi: 10.1186/s13023-018-0796-4 Link
2017
Brixner, D., Maniadakis, N., Kaló, Z., Hu, S., Shen, J., Wijaya, K. (2017). Applying Multi-Criteria Decision Analysis (MCDA) Simple Scoring as an Evidence-based HTA Methodology for Evaluating Off-Patent Pharmaceuticals (OPPs) in Emerging Markets. Value in Health Regional Issues, 13, 1-6. doi: 10.1016/j.vhri.2017.02.001 Link
Coyle, K., Coyle, D., Lester-George, A., West, R., Nemeth, B., Hiligsmann, M., Trapero-Bertran, M., Leidl, R., Pokhrel, S. (2017). Development and application of an economic model (EQUIPTMOD) to assess the impact of smoking cessation. Addiction, 113, 7-18. doi: 10.1111/add.14001 Link
Elek, P., Harsányi, A., Zelei, T., Csetneki, K., Kaló, Z. (2017). Policy objective of generic medicines from the investment perspective: The case of clopidogrel. Health Policy, 121(5), 558-565. doi: 10.1016/j.healthpol.2017.02.015 Link
Elek, P., Takács, E., Merész, G., Kaló, Z. (2016). Implication of external price referencing and parallel trade on pharmaceutical expenditure: indirect evidence from lower-income European countries. Health Policy and Planning, czw133. doi: 10.1093/heapol/czw133 Link
Huber, M. B., Präger, M., Coyle, K., Coyle, D., Lester-George, A., Trapero-Bertran, M., Nemeth, B., Cheung, K. L., Stark, R., Vogl, M., Pokhrel, S., Leidl, R. (2017). Cost-effectiveness of increasing the reach of smoking cessation interventions in Germany: results from the EQUIPTMOD. Addiction, 113, 52-64. doi: 10.1111/add.14062 Link
Inotai, A., Csanádi, M., Harsányi, A., Németh, B. (2017). Drug Policy in Hungary. Value in Health Regional Issues, 13, 16-22. doi: 10.1016/j.vhri.2017.06.003 Link
Inotai, A., Csanadi, M., Vitezic, D., Francetic, I., Tesar, T., Bochenek, T., Lorenzovici, L., Dylst, P., Kalo, Z. (2017). Policy Practices to Maximise Social Benefit from Biosimilars. Journal of Bioequivalence & Bioavailability, 09(04). doi: 10.4172/jbb.1000346 Link
Inotai, A., Prins, C. P. J., Csanádi, M., Vitezic, D., Codreanu, C., Kaló, Z. (2017). Is there a reason for concern or is it just hype? – A systematic literature review of the clinical consequences of switching from originator biologics to biosimilars. Expert Opinion on Biological Therapy, 17(8), 915-926. doi: 10.1080/14712598.2017.1341486 Link
Kaló, Z., Abonyi-Tóth, Z., Rokszin, G., Ágh, T., Inotai, A. (2017). Impact of multiple switching on health care costs and outcomes in generic drug policies: The Hungarian case of losartan. Acta Poloniae Pharmaceutica-Drug Research, 74(4), 1295-1300. Link
Kaló, Z., Vokó, Z., Östör, A., Clifton-Brown, E., Vasilescu, R., Battersby, A., Gibson, E. (2017). Patient access to reimbursed biological disease-modifying antirheumatic drugs in the European region. Journal of Market Access & Health Policy, 5(1), 1345580. doi: 10.1080/20016689.2017.1345580 Link
Kawalec, P., Tesar, T., Vostalova, L., Draganic, P., Manova, M., Savova, A., Petrova, G., Rugaja, Z., Männik, A., Sowada, C., Stawowczyk, E., Harsanyi, A., Inotai, A., Turcu-Stiolica, A., Gulbinovič, J., Pilc, A. (2017). Pharmaceutical Regulation in Central and Eastern European Countries: A Current Review. Frontiers in Pharmacology, 8. doi: 10.3389/fphar.2017.00892 Link
Kovács, G., Somogyvári, Z., Maka, E., Nagyjánosi, L. (2017). Bedside ROP screening and telemedicine interpretation integrated to a neonatal transport system: Economic aspects and return on investment analysis. Early Human Development, 106-107, 1-5. doi: 10.1016/j.earlhumdev.2017.01.007 Link
Molnár, A., Nagy, B., Kerpel-Fronius, A., Bajzik, G., Horváth, I., Moizs, M., Vokó, Z. (2017). Modelling Patient Pathways Of Low-Dose Computed Tomography Screening For Lung Cancer In Hungary. Value in Health, 20(9), A750. doi: 10.1016/j.jval.2017.08.2096 Link
Nagy, B., Setyawan, J., Coghill, D., Soroncz-Szabo, T., Kalo, Z., Doshi, J.A. (2017). A conceptual framework for a long-term economic model of the treatment of attention-deficit/hyperactivity disorder. Expert Review of Pharmacoeconomics & Outcomes Research 17. 3. 283-292. doi: 10.1080/14737167.2017.1271325 Link
Narbutas, Š., York, K., Stein, B. D., Magsanoc-Alikpala, K., Majima, Y., Kalo, Z., Almasi, T., Inotai, A. (2017). Overview on Patient Centricity in Cancer Care. Frontiers in Pharmacology, 8. doi: 10.3389/fphar.2017.00698 Link
Németh, B., Csanádi, M., Kaló, Z. (2017). Overview on the current implementation of health technology assessment in the healthcare system in Hungary. International Journal of Technology Assessment in Health Care, 33(3), 333-338. doi: 10.1017/s0266462317000071 Link
Németh, B., Molnár, A., Akehurst, R., Horváth, M., Kóczián, K., Németh, G., Götze, Á., Vokó, Z. (2017). Quality-adjusted life year difference in patients with predominant negative symptoms of schizophrenia treated with cariprazine and risperidone. Journal of Comparative Effectiveness Research, 6(8), 639-648. doi: 10.2217/cer-2017-0024 Link
Pitter, J. G., Horváth, B., Abonyi-Tóth, Z., Rokszin, G., Fadgyas-Freyler, P., Kovács, G., Ács, N., Kaló, Z., Vokó, Z. (2017). Drug-associated miscarriage, teratogenicity and low birthweight risks: Methods for population-based case-control studies in Hungary. Reproductive Toxicology, 72, 26. doi: 10.1016/j.reprotox.2017.06.064 Link
Rosselli, D., Quirland-Lazo, C., Csanádi, M., Ruiz de Castilla, E. M., González, N. C., Valdés, J., Abicalaffe, C., Garzón, W., Leon, G., Kaló, Z. (2017). HTA Implementation in Latin American Countries: Comparison of Current and Preferred Status. Value in Health Regional Issues, 14, 20-27. doi: 10.1016/j.vhri.2017.02.004 Link
Tesar, T., Szilberhorn, L., Nemeth, B., Nagy, B., Wawruch, M., Kalo, Z. (2017). Cost-Utility Analysis of Heberprot-P as an Add-on Therapy to Good Wound Care for Patients in Slovakia with Advanced Diabetic Foot Ulcer. Frontiers in Pharmacology, 8. doi: 10.3389/fphar.2017.00946 Link
Voko, Z., Barra, M., Molnar, A., Kerpel-Fronius, A., Bajzik, G., Horvath, I., Moizs, M., Nagy, B. (2017). Model concept of the health economic evaluation of low-dose CT lung cancer screening in Hungary. [in Hungarian] ORVOSI HETILAP 158.25. pp. 963–975. doi: 10.1556/650.2017.30731 Link
Vokó, Z., Gáspár, K., Inotai, A., Horváth, C., Bors, K., Speer, G., Kaló, Z. (2017). Osteoporotic fractures may impair life as much as the complications of diabetes. Journal of Evaluation in Clinical Practice, 23(6), 1375-1380. doi: 10.1111/jep.12800 Link
2016
Ágh, T., Kovács, G., Supina, D., Pawaskar, M., Herman, B. K., Vokó, Z., Sheehan, D. V. (2016). A systematic review of the health-related quality of life and economic burdens of anorexia nervosa, bulimia nervosa, and binge eating disorder. Eating and Weight Disorders - Studies on Anorexia, Bulimia and Obesity, 21(3), 353-364. doi: 10.1007/s40519-016-0264-x Link
Ágh, T., Pawaskar, M., Nagy, B., Lachaine, J., Vokó, Z. (2016). The Cost Effectiveness of Lisdexamfetamine Dimesylate for the Treatment of Binge Eating Disorder in the USA. Clinical Drug Investigation, 36(4), 305-312. doi: 10.1007/s40261-016-0381-3 Link
Bodnár, R., Meszaros, A., Olah, M., Agh, T. (2016). Inhaled antibiotics for the treatment of chronic Pseudomonas aeruginosa infection in cystic fibrosis patients: challenges to treatment adherence and strategies to improve outcomes. Patient Preference and Adherence, 183. doi: 10.2147/ppa.s53653 Link
Cheung, K. L., Evers, S. M. A. A., Hiligsmann, M., Vokó, Z., Pokhrel, S., Jones, T., Muñoz, C., Wolfenstetter, S. B., Józwiak-Hagymásy, J., de Vries, H. (2016). Understanding the stakeholders’ intention to use economic decision-support tools: A cross-sectional study with the tobacco return on investment tool. Health Policy, 120(1), 46-54. doi: 10.1016/j.healthpol.2015.11.004 Link
Elek, P., Takács, E., Merész, G., Kaló, Z. (2016). Implication of external price referencing and parallel trade on pharmaceutical expenditure: indirect evidence from lower-income European countries. Health Policy and Planning, czw133. doi: 10.1093/heapol/czw133 Link
Glonti, K., Pitter, J., Csanadi, M., Vokó, Z., McKee, M. (2016). Health system factors associated with uptake of cancer screening: an overview of systematic reviews. European Journal of Public Health, 26(suppl_1). doi: 10.1093/eurpub/ckw169.068 Link
Inotai, A., Csanadi, M., Agh, T. (2016). Real-world data analysis to improve drug policy decision-making in Central Eastern European countries. [in Hungarian] IME INTERDISZCIPLINARIS MAGYAR EGESZSEGUGY 15: 47-52. Link
Kaló, Z., Gheorghe, A., Huic, M., Csanádi, M., Kristensen, F. B. (2016). HTA Implementation Roadmap in Central and Eastern European Countries. Health Economics, 25, 179-192. doi: 10.1002/hec.3298 Link
Kaló, Z., Vokó, Z., Akhras, K. S., Kanavos, P. (2016). Response to: Comment on the implications of external price referencing of pharmaceuticals in Middle East countries. Expert Review of Pharmacoeconomics & Outcomes Research, 16(1), 15-16. doi: 10.1586/14737167.2016.1136792 Link
Kaló, Z., Vokó, Z., Clifton-Brown, E., Vasilescu, R. S., David, T., Gibson, E., Begum, N., Rao, N. (2016). Impact of National Criteria and Healthcare System Characteristics on Access to Biologic Dmards in Rheumatoid Arthritis In Europe. Value in Health, 19(7), A547-A548. doi: 10.1016/j.jval.2016.09.1163 Link
Kolasa, K., Zwolinski, K. M., Kalo, Z., Hermanowski, T. (2016). Potential impact of the implementation of multiple-criteria decision analysis (MCDA) on the Polish pricing and reimbursement process of orphan drugs. Orphanet Journal of Rare Diseases, 11(1). doi: 10.1186/s13023-016-0388-0 Link
Kolasa, K., Kalo, Z., Zah, V. (2016). The use of non-economic criteria in pricing and reimbursement decisions in Central and Eastern Europe: issues, trends and recommendations. Expert Review of Pharmacoeconomics & Outcomes Research, 16(4), 483-488. doi: 10.1080/14737167.2016.1215917 Link
Kovács, G., Zelei, T., Vokó, Z. (2016). Comparison of efficacy and local tolerability of estradiol metered-dose transdermal spray to estradiol patch in a network meta-analysis. Climacteric, 19(5), 488-495. doi: 10.1080/13697137.2016.1221919 Link
Marsh, K., Ijzerman, M., Thokala, P., Baltussen, R., Boysen, M., Kaló, Z., Lönngren, T., Mussen, F., Peacock, S., Watkins, J., Devlin, N. (2016). Multiple Criteria Decision Analysis for Health Care Decision Making—Emerging Good Practices: Report 2 of the ISPOR MCDA Emerging Good Practices Task Force. Value in Health, 19(2), 125-137. doi: 10.1016/j.jval.2015.12.016 Link
Nagy, B., Zsólyom, A., Nagyjánosi, L., Merész, G., Steiner, T., Papp, E., Dessewffy, Z., Jermendy, G., Winkler, G., Kaló, Z., Vokó, Z. (2016). Cost-effectiveness of a risk-based secondary screening programme of type 2 diabetes. Diabetes/Metabolism Research and Reviews, 32(7), 710-729. doi: 10.1002/dmrr.2791 Link
Nagy, B., Setyawan, J., Coghill, D., Soroncz-Szabó, T., Kaló, Z., Doshi, J. A. (2016). A conceptual framework for a long-term economic model for the treatment of attention-deficit/hyperactivity disorder. Expert Review of Pharmacoeconomics & Outcomes Research, 17(3), 283-292. doi: 10.1080/14737167.2017.1271325 Link
Vokó, Z., Cheung, K. L., Józwiak-Hagymásy, J., Wolfenstetter, S., Jones, T., Muñoz, C., Evers, S. M. A. A., Hiligsmann, M., de Vries, H., Pokhrel, S. (2016). Similarities and differences between stakeholders’ opinions on using Health Technology Assessment (HTA) information across five European countries: results from the EQUIPT survey. Health Research Policy and Systems, 14(1). doi: 10.1186/s12961-016-0110-7 Link
Thokala, P., Devlin, N., Marsh, K., Baltussen, R., Boysen, M., Kalo, Z., Longrenn, T., Mussen, F., Peacock, S., Watkins, J., Ijzerman, M. (2016). Multiple Criteria Decision Analysis for Health Care Decision Making-An Introduction: Report 1 of the ISPOR MCDA Emerging Good Practices Task Force. Value Health. 2016. 19(1). 1-13. doi: 10.1016/j.jval.2015.12.003 Link
Voko, Z., Turi, G., Zsolyom, A. (2016). Cost-effectiveness of oral cancer screening in Hungary. [in Hungarian] ORVOSI HETILAP 157(29), 1161–1170. doi: 10.1556/650.2016.30447 Link
Voko, Z., Zsolyom, A., Jermendy, Gy. (2016). Diabetes attributable mortality in Hungary in 2000-2009.[in Hungarian] LEGE ARTIS MEDICINAE 26:265-270. Link
Zelei, T., Molnár, M. J., Szegedi, M., Kaló, Z. (2016). Systematic review on the evaluation criteria of orphan medicines in Central and Eastern European countries. Orphanet Journal of Rare Diseases, 11(1). doi: 10.1186/s13023-016-0455-6 Link
Zemplenyi, A.T., Mangel, L., Kalo, Z., Endrei, D., Boncz, I. (2016). A microcosting study of radiation therapy of localized prostate cancer. (in Hungarian) ORVOSI HETILAP 157. 12. 461-8. doi: 10.1556/650.2016.30392 Link
Zemplenyi, A.T., Mangel, L., Kalo, Z., Endrei, D., Lohner, S., Boncz, I. (2016). Meta-analysis of the side-effect profiles of modern radiation therapies for patients with prostate cancer (Article in Hungarian). ORVOSI HETILAP 157(20):776-88. doi: 10.1556/650.2016.30422 Link
Zemplényi, A.T., Kaló, Z., Kovács, G., Farkas, R., Beöthe, T., Bányai, D., Sebestyén, Z., Endrei, D., Boncz, I., Mangel, L. (2016). Cost-effectiveness analysis of intensity-modulated radiation therapy with normal and hypofractionated schemes for the treatment of localised prostate cancer. European Journal of Cancer Care, 27(1), e12430. doi: 10.1111/ecc.12430 Link
2015
Ágh, T., Bodnár, R., Oláh, M., Mészáros, Á. (2015). Adherence to Inhaled Antibiotics for The Treatment of Chronic Pseudomonas Aeruginosa Infection In Patients With Cystic Fibrosis: A Systematic Literature Review. Value in Health, 18(7), A760. doi: 10.1016/j.jval.2015.09.2480 Link
Ágh, T., Kovács, G., Pawaskar, M., Supina, D., Inotai, A., Vokó, Z. (2015). Epidemiology, health-related quality of life and economic burden of binge eating disorder: a systematic literature review. Eating and Weight Disorders - Studies on Anorexia, Bulimia and Obesity, 20(1), 1-12. doi: 10.1007/s40519-014-0173-9 Link
Ágh, T., Dömötör, P., Bártfai, Z., Inotai, A., Fujsz, E., Mészáros, Á. (2015). Relationship between medication adherence and health-related quality of life in subjects with COPD: a systematic review. Respiratory Care, 60(2), 297-303. doi: Link
Bartfai, Z., Agh, T., Domotor, P., Bartfai, L., Meszaros, A. (2015). Therapeutic opportunities derived from clinical differences among inhaled corticosteroids. [in Hungarian] MEDICINA THORACALIS 5:339-344.
Drummond, M., Augustovski, F., Kaló, Z., Yang, B.-M., Pichon-Riviere, A., Bae, E.-Y., Kamal-Bahl, S. (2015). CHALLENGES FACED IN TRANSFERRING ECONOMIC EVALUATIONS TO MIDDLE INCOME COUNTRIES. International Journal of Technology Assessment in Health Care, 31(6), 442-448. doi: 10.1017/s0266462315000604 Link
Gyulai, A., Nagy, A., Pataki, V., Tonté, D., Ádány, R., Vokó, Z. (2015). Survey of Participation in Organised Cervical Cancer-Screening Programme in Hungary. Cent Eur J Public Health, 23(4), 360-364. doi: 10.21101/cejph.a4068 Link
Inotai, A., Abonyi-Tóth, Z., Rokszin, G., Vokó, Z. (2015). Prognosis, Cost, and Occurrence of Colorectal, Lung, Breast, and Prostate Cancer in Hungary. Value in Health Regional Issues, 7, 1-8. doi: 10.1016/j.vhri.2015.03.020 Link
Inotai, A., Merész, G., Csetneki, K., Kaló, Z. (2015). A gyógyszerkiadások nemzetközi összehasonlításának módszertani kérdései és ezek hatásai a magyarországi kormányzati intézkedésekre. IME. 2015. 14. 8. 55-60. Link
Jozwiak-Hagymasy, J., Voko, Z. (2015). Use of inhalation devices in asthma and chronic obstructive pulmonary disease: a Delphi consensus panel [in Hungarian] IME 14:1 48:53. Link
Kaló, Z., Alabbadi, I., Al Ahdab, O. G., Alowayesh, M., Elmahdawy, M., Al-Saggabi, A. H., Tanzi, V. L., Al-Badriyeh, D., Alsultan, H. S., Ali, F. M. H., Elsisi, G. H., Akhras, K. S., Vokó, Z., Kanavos, P. (2015). Implications of external price referencing of pharmaceuticals in Middle East countries. Expert Review of Pharmacoeconomics & Outcomes Research, 15(6), 993-998. doi: 10.1586/14737167.2015.1048227 Link
Kaló, Z., Holtorf, A.-P., Alfonso-Cristancho, R., Shen, J., Ágh, T., Inotai, A., Brixner, D. (2015). Need for Multicriteria Evaluation of Generic Drug Policies. Value in Health, 18(2), 346-351. doi: 10.1016/j.jval.2014.12.012 Link
Kind, P., Vokó, Z. (2015). A National Eq-5d Value Set for Hungary - a Model Methodology? Value in Health, 18(7), A738. doi: 10.1016/j.jval.2015.09.2833 Link
Mandrik, O., Knies, S., Kalo, Z., Severens, J. L. (2015). REVIEWING TRANSFERABILITY IN ECONOMIC EVALUATIONS ORIGINATING FROM EASTERN EUROPE. International Journal of Technology Assessment in Health Care, 31(6), 434-441. doi: 10.1017/s0266462315000677 Link
Nagy, B. (2015). Improving the allocation of health care resources in Poland. WORLD HEALTH ORGANIZATION REGIONAL OFFICE FOR EUROPE. Link
Oyebode, O., Garrett, Z., George, E., Cangini, A., Muscolo, L. A. A., Warren, S., Nemeth, B., Földesi, C., Heislerová, M., Gajdošová, E. (2015). EVIDENCE REQUIREMENTS FOR REIMBURSEMENT OF PHARMACEUTICALS ACROSS EUROPE. International Journal of Technology Assessment in Health Care, 31(1-2), 59-67. doi: 10.1017/s0266462315000227 Link
Pawaskar, M., Vokó, Z., Ágh, T., Sheehan, D. V., McElroy, S. L., Radewonuk, J., Merész, G., Herman, B. K., Gasior, M. (2015). Longitudinal Modeling The Effect Of Lisdexamfetamine Dimesylate And Changes In Binge Eating Frequency On Disability In Patients With Binge Eating Disorder. Value in Health, 18(7), A407. doi: 10.1016/j.jval.2015.09.959 Link
Pawaskar, M., Ágh, T., Radewonuk, J., Vokó, Z., McElroy, S. L., Herman, B. K., Gasior, M. (2015). Longitudinal Modeling Of The Relationship Between Lisdexamfetamine Dimesylate And Health-Related Quality Of Life In Adults With Moderate To Severe Binge Eating Disorder. Value in Health, 18(7), A407. doi: 10.1016/j.jval.2015.09.958 Link
Pitter, J., Jozwiak, A., Martos, E., Kaló, Z., Vokó, Z. (2015). Next steps to evidence-based food safety risk analysis: opportunities for health technology assessment methodology implementation. Studies in Agricultural Economics, 117. 155-161. doi: 10.7896/j.1524 Link
Pitter, J. G., Vokó, Z., Halmos, Á., Józwiak, Á. (2015). Cost-Utility Analysis of Potential Campylobacter Control Measures in the Food Chain of Indoor Broiler Chicken in the Eu. Value in Health, 18(7), A649. doi: 10.1016/j.jval.2015.09.2331 Link
Sebestyén, A., Mester, S., Vokó, Z., Gajdácsi, J., Cserháti, P., Speer, G., Patczai, B., Warta, V., Bódis, J., Horváth, C., Boncz, I. (2015). Wintertime surgery increases the risk of conversion to hip arthroplasty after internal fixation of femoral neck fracture. Osteoporosis International, 26(3), 1109-1117. doi: 10.1007/s00198-014-2966-0 Link
Vokó, Z., Beran, D., Pusztai, Zs., Bak Pedersen, H., Evetovits, T., Szigeti, Sz. (2015). Better non-communicable disease outcomes: challenges and opportunities for health systems. Hungary Country Assessment: Focus on diabetes 2014. WHO REGIONAL OFFICE FOR EUROPE. Link
2014
Adany, R., Voko, Z. (2014). Hungarian public health - ups and downs in the last 20 years. The European Journal of Public Health, 24(3), 352-353. doi: 10.1093/eurpub/cku034 Link
Ágh, T., Pawaskar, M., Kovacs, G., Kalo, Z., Supina, D., Voko, Z. (2014). The humanistic and economic burden of bulimia nervosa and binge eating disorder: A systematic literature review. Value in Health, 17(3), A213. doi: 10.1016/j.jval.2014.03.1249 Link
Elsisi, G. H., Eldessouki, R., Kalo, Z., Elmazar, M. M., Taha, A. S., Awad, B. F., El-Hamamsy, M. H. (2014). Cost-Effectiveness of the Combined Use of Warfarin and Low-Dose Aspirin versus Warfarin Alone in Egyptian Patients with Aortic Valve Replacements: A Markov Model. Value in Health Regional Issues, 4, 24-30. doi: 10.1016/j.vhri.2014.06.004 Link
Gregory, V., Barbeau, M., Machnicki, G., Voko, Z., Heisel, O., Keown, P. (2014). Real world research in Latin America: Opportunities, sources and barriers. Value in Health, 17(3), A188. doi: 10.1016/j.jval.2014.03.1099 Link
Inotai, A., Abonyi-Tóth, Z., Rokszin, G., Voko, Z. (2014). Occurrence, Survival And Annual Cost of Colorectal-, Breast-, Prostate- and Lung Cancer in Hungary. Value in Health, 17(7), A553. doi: 10.1016/j.jval.2014.08.1809 Link
Inotai, A., Petrova, G., Vitezic, D., Kaló, Z. (2014). Benefits of investment into modern medicines in Central-Eastern European countries. Expert Review of Pharmacoeconomics and Outcomes Research, 14(1), 71-79. doi: 10.1586/14737167.2014.868314 Link
Kaló, Z., Antal, J., Pénzes, M., Pozsgay, C., Szepezdi, Z., Nagyjánosi, L. (2014). Contribution of clinical trials to gross domestic product in Hungary. Croatian Medical Journal, 55(5), 446-451. doi: 10.3325/cmj.2014.55.446 Link
Kalo, Z., Boncz, I., Dank, M., Koczian, K., Molnar, M.J., Nagy, B., Nemeth, Gy., Pitter, J., Zelei, T. (2014). Health Economic Aspects of Personalized Medicine: Do Personalized Technologies Reduce Health Expenditure? [in Hungarian] IME 13. 5. 41-45. Link
Kolasa, K., Kaló, Z., Hornby, E. (2014). Pricing and reimbursement frameworks in Central Eastern Europe: a decision tool to support choices. Expert Review of Pharmacoeconomics & Outcomes Research, 15(1), 145-155. doi: 10.1586/14737167.2014.898566 Link
Kovács, G., Kaló, Z., Jahnz-Rozyk, K., Kyncl, J., Csohan, A., Pistol, A., Leleka, M., Kipshakbaev, R., Durand, L., Macabeo, B. (2014). Medical and economic burden of influenza in the elderly population in central and eastern European countries. Hum Vaccin Immunother, 10(2), 428-440. doi: 10.4161/hv.26886 Link
Kwong, D., Ferrario, A., Adamski, J., Inotai, A., Kaló, Z. (2014). Managing the introduction of new and high-cost drugs in challenging times: the experience of Hungary and Poland. EuroHealth, 20(2), 25-28. Link
Lorenzovici, L., Székely, A., Ágh, T., Vámossy, I., Kelemen, L. J., Finta, H., Kaló, Z. (2014). Economic Evaluation of Ulipristal Acetate for the Treatment of Patients With Moderate and Severe Symptoms of Uterine Fibroids in Romania. Value in Health, 17(7), A510. doi: 10.1016/j.jval.2014.08.1563 Link
Meresz, G., Foldesi, Cs., Nagyistok, Sz., Vincziczki, A. (2014). Changes on the market of publications and a dynamising health economic researcher community [in Hungarian]. EGESZSEGUGYI GAZDASAGI SZEMLE 2014/2-3, p36-41. Link
Nagy, B., Timár, G., Józwiak-Hagymásy, J., Kovács, G., Merész, G., Vámossy, I., Ágh, T., László, Á., Vokó, Z., Kaló, Z. (2014). The cost-effectiveness of ulipristal acetate tablets in treating patients with moderate to severe symptoms of uterine fibroids. European Journal of Obstetrics & Gynecology and Reproductive Biology, 175, 75-81. doi: 10.1016/j.ejogrb.2014.01.022 Link
Pokhrel, S., Evers, S., Leidl, R., Trapero-Bertran, M., Kalo, Z., Vries, H. d., Crossfield, A., Andrews, F., Rutter, A., Coyle, K., Lester-George, A., West, R., Owen, L., Jones, T., Vogl, M., Radu-Loghin, C., Voko, Z., Huic, M., Coyle, D. (2014). EQUIPT: protocol of a comparative effectiveness research study evaluating cross-context transferability of economic evidence on tobacco control. BMJ Open, 4(11), e006945. doi: 10.1136/bmjopen-2014-006945 Link
Sebestyén, A., Mester, S., Vokó, Z., Gajdácsi, J., Cserháti, P., Speer, G., Patczai, B., Warta, V., Bódis, J., Horváth, C., Boncz, I. (2014). Wintertime surgery increases the risk of conversion to hip arthroplasty after internal fixation of femoral neck fracture. Osteoporosis International, 26(3), 1109-1117. doi: 10.1007/s00198-014-2966-0 Link
Strain, W. D., Cos, X., Hirst, M., Vencio, S., Mohan, V., Vokó, Z., Yabe, D., Blüher, M., Paldánius, P. M. (2014). Time to do more: Addressing clinical inertia in the management of type 2 diabetes mellitus. Diabetes Research and Clinical Practice, 105(3), 302-312. doi: 10.1016/j.diabres.2014.05.005 Link
Vokó, Z., Németh, R., Nagyjánosi, L., Jermendy, G., Winkler, G., Hídvégi, T., Kalotai, Z., Kaló, Z. (2014). Mapping the Nottingham Health Profile onto the Preference-Based EuroQol-5D Instrument for Patients with Diabetes. Value in Health Regional Issues, 4, 31-36. doi: 10.1016/j.vhri.2014.06.002 Link
Vokó, Z., Beran, D., Pusztai, Z., Bak Pedersen, H., Evetovits, T., Szigeti, S. (2014). Better non-communicable disease outcomes: challenges and opportunities for health systems. Hungary Country Assessment: Focus on diabetes. Link
Zsólyom, A., Nagy, B., Dessewffy, Z., Steiner, T., Kaló, Z., Vokó, Z. (2014). Cost-effectiveness of the introduction of a risk stratified population screening for type 2 diabetes in hungary. Value in Health, 17(3), A259. doi: 10.1016/j.jval.2014.03.1509 Link
Zsólyom, A., Nagy, B., Nagyjánosi, L., Dessewffy, Z., Steiner, T., Kaló, Z., Vokó, Z. (2014). Cost-Effectiveness of The introduction of A National Adherence Program for Type 2 Diabetes In Hungary. Value in Health, 17(7), A358. doi: 10.1016/j.jval.2014.08.770 Link
2013
Agh, T., Meszaros, A., Bartfai, Z. (2013). Quality of life and adherence in chronic obstructive pulmonary disease [in Hungarian]. MEDICAONLINE Link
Boncz, I., Kaló, Z., Mohamed Ibrahim, M. I. B., Greenberg, D. (2013). Further Steps in the Development of Pharmacoeconomics, Outcomes Research, and Health Technology Assessment in Central and Eastern Europe, Western Asia, and Africa. Value in Health Regional Issues, 2(2), 169-170. doi: 10.1016/j.vhri.2013.07.007 Link
Elsisi, G. H., Kaló, Z., Eldessouki, R., Elmahdawy, M. D., Saad, A., Ragab, S., Elshalakani, A. M., Abaza, S. (2013). Recommendations for Reporting Pharmacoeconomic Evaluations in Egypt. Value in Health Regional Issues, 2(2), 319-327. doi: 10.1016/j.vhri.2013.06.014 Link
Merész, G., Németh, B., Sinkovits, B. (2013). Conference report. Acta Oeconomica, 63(3), 377-381. doi: 10.1556/aoecon.63.2013.3.7 Link
Kaló, Z., Annemans, L., Garrison, L. P. (2013). Differential pricing of new pharmaceuticals in lower income European countries. Expert Review of Pharmacoeconomics & Outcomes Research, 13(6), 735-741. doi: 10.1586/14737167.2013.847367 Link
Kaló, Z., Bodrogi, J., Boncz, I., Dózsa, C., Jóna, G., Kövi, R., Pásztélyi, Z., Sinkovits, B. (2013). Capacity Building for HTA Implementation in Middle-Income Countries: The Case of Hungary. Value in Health Regional Issues, 2(2), 264-266. doi: 10.1016/j.vhri.2013.06.002 Link
Orosz, E., Meresz, G., Nagy, B. (2013). Investment to human capital: fallback from the developed countries? [in Hungarian] EDUCATIO. Volume 22, Number 2, 2013., p159-176. Link
Szabó, L., Jackowska, T., Kaló, Z., Kulcsár, A., Mészner, Z., Molnár, Z., Wysocki, J., Wutzler, P., Kormos-Tasi, J., Sauboin, C. (2013). Varicella vaccination in Hungary and Poland: optimization of public benefits from prophylaxis technologies in the time of austerity. New Medicine. Link
Szabó, R. P., Klenk, N., Balla, J., Asztalos, L., Szabó, L., Vokó, Z. (2013). Prognosis of Dialysed Patients after Kidney Transplant Failure. Kidney and Blood Pressure Research, 37(2-3), 151-157. doi: 10.1159/000350140 Link
Voko, Z., Inotai, A., Horvath, Cs., Bors, K., Speer, G., Kalo, Z. (2013). Quality of Life of Patients With Osteoporosis In Hungary. [in Hungarian] Lege Artis Medicinae 3(4). Link
Voko, Z., Nemeth, R., Dank, M., Nagy-Erdei, Z., Kalo, Z., Geczi, L. (2013). Mapping the Cancer-Specific EORTC QLQ-BR23 onto the Preference-Based EuroQol-5D Instrument. Journal of Health Policy and Outcomes Research(2), 90-99. doi: 10.7365/JHPOR.2013.4.10 Link
Zsólyom, A., Merész, G., Nagyjánosi, L., Nagyistók, S., Nagy, B., Kaló, Z., Vokó, Z. (2013). External Validation of the Syreon Diabetes Model. Value in Health, 16(7), A590. doi: 10.1016/j.jval.2013.08.1640 Link
2012
Borsos, G., Vokó, Z., Gredes, T., Kunert-Keil, C., Vegh, A. (2012). Tooth movement using palatal implant supported anchorage compared to conventional dental anchorage. Annals of Anatomy - Anatomischer Anzeiger, 194(6), 556-560. doi: 10.1016/j.aanat.2012.08.003 Link
Inotai, A., Agh, T., Meszaros, A. (2012). Quality of life, utility and health burden in asthma, chronic obstructive pulmonary disease and rheumatoid arthritis. International Journal of Person Centered Medicine, 2(3), 505-510. doi: 10.5750/ijpcm.v2i3.254 Link
Inotai, A., Kalo, Z. (2012). Risk sharing methods in middle income countries [in Hungarian]. ACTA PHARMACEUTICA HUNGARICA 82: 43-52. Link
Inotai, A., Meszaros, A. (2012). Determinants of NSAID choice in rheumatoid arthritis--a drug utilization study. Acta poloniae pharmaceutica, 69(4), 773-777. Link
Inotai, A., Nagy, B., Kalo, Z. (2012). Biosimilars and evidence based decision making in Central Eastern European countries. [in Hungarian] ORVOSTOVABBKEPZO SZEMLE 19: 69-73. Link
Inotai, A., Nuijten, M., Roth, E., Hegazi, R., Kaló, Z. (2012). Modelling the burden of disease associated malnutrition. e-SPEN Journal, 7(5), e196-e204. doi: 10.1016/j.clnme.2012.07.003 Link
Inotai, A., Pékli, M., Jóna, G., Nagy, O., Remák, E., Kaló, Z. (2012). Attempt to increase the transparency of fourth hurdle implementation in Central-Eastern European middle income countries: publication of the critical appraisal methodology. BMC Health Services Research, 12(1). doi: 10.1186/1472-6963-12-332 Link
Kalo, Z., Abonyi-Toth, Z., Bartfai, Z., Voko, Z. (2012). Pitfalls associated with the therapeutic reference pricing practice of asthma medication. BMC Pulmonary Medicine, 12(1). doi: 10.1186/1471-2466-12-35 Link
Kaló, Z., Boncz, I., Inotai, A. (2012). Implications of economic crisis on health care decision-making in Hungary: An opportunity to change. Journal of Health Policy and Outcomes Research, 1, 20-26. Link
Kaló, Z., Landa, K., Doležal, T., Vokó, Z. (2012). Transferability of National Institute for Health and Clinical Excellence recommendations for pharmaceutical therapies in oncology to Central-Eastern European countries. European Journal of Cancer Care, 21(4), 442-449. doi: 10.1111/j.1365-2354.2012.01351.x Link
Kalo, Z., Meresz, G., Mezei, D., Totth, A., Inotai, A. (2012). The grounding and implications of Szell Kalman Plan [in Hungarian]. IME AZ EGESZSEGUGYI VEZETOK SZAKLAPJA 11:6 12-16. Link
Kalo, Z., Nagy, B. (2012). Methodological questions in assessing the cost effectiveness of prevention programs. [in Hungarian] EGESZSEGUGYI GAZDASAGI SZEMLE 50:1 29-31. Link
Kolasa, K., Kalo, Z., Zah, V., Doležal, T. (2012). Role of health technology assessment in the process of implementation of the EU Transparency Directive: relevant experience from Central Eastern European countries. Expert Review of Pharmacoeconomics & Outcomes Research, 12(3), 283-287. doi: 10.1586/erp.12.12 Link
Meresz, G., Tabak, A., Kalo, Z. (2012). Cost minimisation analysis of basal insulin analogues for treatment of type 2 diabetes. [in Hungarian] LEGE ARTIS MEDICINAE 22(12):669–676. Link
Meszaros, A., Agh, T., Bartfai, Z., Orosz, M. (2012). Quality of life decrement and health burden in asthma and COPD [in Hungarian]. MEDICINA THORACALIS 65: 219.
Nagy, B., Gaspar, I., Papp, A., Bene, Z., Nagy, B., Voko, Z., Balla, G. (2012). Efficacy of methylprednisolone in children with severe community acquired pneumonia. Pediatric Pulmonology, 48(2), 168-175. doi: 10.1002/ppul.22574 Link
Nagy, B., Meresz, G. (2012). Role of risk-sharing in health care. [in Hungarian] EGESZSEGUGYI GAZDASAGI SZEMLE November 1; 50(4): 42-48. Link
Nagy, B., Nagyjanosi, L., Nagyistok, Sz., Jozwiak-Hagymasy, J., Meresz, G., Papp, E., Dessewffy, Z., Jermendy, Gy., Winkler, G., Kalo, Z., Voko, Z. (2012). Health economic model to assess the screening, treatment and management strategies of diabetes. [in Hungarian] DIABETOLOGIA HUNGARICA 20.4 p.245-255. Link
Papp, K., Végh, P., Hóbor, R., Szittner, Z., Vokó, Z., Podani, J., Czirják, L., Prechl, J. (2012). Immune Complex Signatures of Patients with Active and Inactive SLE Revealed by Multiplex Protein Binding Analysis on Antigen Microarrays. PLoS ONE, 7(9), e44824. doi: 10.1371/journal.pone.0044824 Link
Petrovski, B. É., Pataki, V., Jenei, T., Ádány, R., Vokó, Z. (2012). Selenium levels in men with liver disease in Hungary. Journal of Trace Elements in Medicine and Biology, 26(1), 31-35. doi: 10.1016/j.jtemb.2012.01.001 Link
Szigethy, E., Széles, G., Horváth, A., Hidvégi, T., Jermendy, G., Paragh, G., Blaskó, G., Ádány, R., Vokó, Z. (2012). Epidemiology of the metabolic syndrome in Hungary. Public Health, 126(2), 143-149. doi: 10.1016/j.puhe.2011.11.003 Link
Vokó, Z., Kaló, Z. (2012). Prevenció - kiadások – hatékonyság, Egészségügyi Gazdasági Szemle, 2012. 50. 1. 6-8. Link
Vokó, Z., Nagyjánosi, L., Kaló, Z. (2012). Cost-effectiveness of adding vaccination with the AS04-adjuvanted human papillomavirus 16/18 vaccine to cervical cancer screening in Hungary. BMC Public Health, 12(1). doi: 10.1186/1471-2458-12-924 Link
Vokó, Z., Nagyjánosi, L., Margitai, B., Kövi, R., Tóth, Z., László, D., Kaló, Z. (2012). Modeling Cost-Effectiveness of Cervical Cancer Screening in Hungary. Value in Health, 15(1), 39-45. doi: 10.1016/j.jval.2011.10.003 Link
Walter, S., Mackenbach, J., Vokó, Z., Lhachimi, S., Ikram, M. A., Uitterlinden, A. G., Newman, A. B., Murabito, J. M., Garcia, M. E., Gudnason, V., Tanaka, T., Tranah, G. J., Wallaschofski, H., Kocher, T., Launer, L. J., Franceschini, N., Schipper, M., Hofman, A., Tiemeier, H. (2012). Genetic, Physiological, and Lifestyle Predictors of Mortality in the General Population. American Journal of Public Health, 102(4), e3-e10. doi: 10.2105/ajph.2011.300596 Link
2011
Agh, T., Inotai, A., Meszaros, A. (2011). Factors Associated with Medication Adherence in Patients with Chronic Obstructive Pulmonary Disease. Respiration, 82(4), 328-334. doi: 10.1159/000324453 Link
Barkai, L., Blatniczky, L., Halmos, T., Hidvégi, T., Jermendy, Gy., Kaló, Z., Madácsy, L., Vándorfi, Gy., Winkler, G., Wittmann, I. (2011). Nemzeti Diabetesprogram. Diabetologia Hungarica, 2011. 19. 3. Supplementum 5-39. Link
Gorog, K., Pattenden, S., Antova, T., Niciu, E., Rudnai, P., Scholtens, S., Splichalova, A., Slotova, K., Vokó, Z., Zlotkowska, R., Houthuijs, D. (2011). Maternal smoking during pregnancy and childhood obesity: results from the CESAR Study. Maternal & Child Health Journal, 15(7), 985-992. doi: 10.1007/s10995-009-0543-5 Link
Inotai, A., Meresz, G., Kalo, Z. (2011). Assessment of Hungarian pharmaceutical expenditures with respect to Szell Kalman Plan [in Hungarian]. EGESZSEGUGYI GAZDASAGI SZEMLE 49: 9-13. Link
Inotai, A., Rojkovich, B., Fülöp, A., Jászay, E., Ágh, T., Mészáros, Á. (2011). Health-related quality of life and utility in patients receiving biological and non-biological treatments in rheumatoid arthritis. Rheumatology International, 32(4), 963-969. doi: 10.1007/s00296-010-1721-x Link
Kaló, Z., Jermendy, Gy., Winkler, G., Hidvégi, T., Borsi, A., Novákné Pékli, M., Kincses, J., Kalotai, Z., Vokó, Z. (2011). A cukorbetegség társadalmi terhe és egészségügyi prioritásának indoka. Diabetologia Hungarica, 2011. 19. 3. 245–251. Link
Kaló, Z., Vokó, Z. (2011). Health technology assessment: a European collaboration. Expert Review of Pharmacoeconomics & Outcomes Research, 11(1), 41-43. doi: 10.1586/erp.10.90 Link
Losonczy, G., Fekete, Á., Vokó, Z., Takács, L., Káldi, I., Ajzner, É., Kasza, M., Vajas, A., Berta, A., Balogh, I. (2011). Analysis of complement factor H Y402H, LOC387715, HTRA1 polymorphisms and ApoE alleles with susceptibility to age-related macular degeneration in Hungarian patients. Acta Ophthalmologica, 89(3), 255-262. doi: 10.1111/j.1755-3768.2009.01687.x Link
Meszaros, A., Szabo, L., Agh, T., Fujsz, E., Bartfai, Z. (2011). Measurement of health related quality of life and asthma control in Hungary [in Hungarian]. TUDOGYOGYASZAT 5: 28-31.
Nagy, B., Brennan, A., Brandtmüller, A., Thomas, S. K., Sullivan, S. D., Akehurst, R. (2011). Assessing the cost-effectiveness of the rivastigmine transdermal patch for Alzheimer's disease in the UK using MMSE- and ADL-based models. International Journal of Geriatric Psychiatry, 26(5), 483-494. doi: 10.1002/gps.2551 Link
Nagy, B., Nagyjanosi, L., Nagyistok, S., Józwiak-Hagymásy, J., Dessewffy, Z., Kalo, Z., Vokó, Z. (2011). PDB82 Development of a Health Economic Model to Compare the Prevention, Treatment and Management Strategies of Type 2 Diabetes. Value in Health, 14(7), A486-A487. doi: 10.1016/j.jval.2011.08.1385 Link
Nagyjanosi, L., Martos, É., Bödönyi, D., Vokó, Z. (2011). PCV67 Health-Economic Impact of the Hungarian Salt Intake Reduction Program. Value in Health, 14(7), A376. doi: 10.1016/j.jval.2011.08.787 Link
Németh, J., Nagyjánosi, L., Nagyistók, Sz., Tolnayné Csattos, M., Szabóné Berta, I., Kincse, É., Szulyák, E., Boér, I., Hundzsa, Gy., Kaló, Z., Berta, A. (2011). Időskori vakság betegségterhe Magyarországon. Lege Artis Medicinae 2011. 21. 10. 641–647. Link
Ohmann, C., Kuchinke, W., Canham, S., Lauritsen, J., Salas, N., Schade-Brittinger, C., Wittenberg, M., McPherson, G., McCourt, J., Gueyffier, F., Lorimer, A., Torres, F. (2011). Standard requirements for GCP-compliant data management in multinational clinical trials. Trials, 12(1). doi: 10.1186/1745-6215-12-85 Link
Papp, K., Végh, P., Hóbor, R., Szittner, Z., Vokó, Z., Podani, J., Korányi, K. L., Czirják, L. K., Prechl, J. (2011). Functional serum antibody profiles in autoimmune disease diagnostics. Molecular Immunology, 48(14), 1732. doi: 10.1016/j.molimm.2011.06.432 Link
Petrovski, B. É., Széles, G., Melles, M., Pataki, V., Kardos, L., Jenei, T., Ádány, R., Vokó, Z. (2011). Behaviour does not fully explain the high risk of chronic liver disease in less educated men in Hungary. European Journal of Public Health, 21(5), 662-666. doi: 10.1093/eurpub/ckq079 Link
Rojkovich, B., Inotai, A. (2011). Cardiovascular safety of nonsteroidal antiinflammatory drugs [in Hungarian]. LEGE ARTIS MEDICINAE 21: 123-125. Link
Szabo, R.P., Asztalos, L., Szabo, L., Balla, J., Vokó, Z. (2011). Validation of a prognostic function for renal transplant recipients in Hungary. Journal of Nephrology 24:(5) pp. 619-624. doi: 10.5301/JN.2011.8354 Link
Vokó, Z., de Brouwer, S., Lubsen, J., Danchin, N., Otterstad, J.-E., Dunselman, P. H. J. M., Kirwan, B.-A. (2011). Long-term impact of secondary preventive treatments in patients with stable angina. European Journal of Epidemiology, 26(5), 375-383. doi: 10.1007/s10654-011-9558-5 Link
2010
Ágh, T., Mészáros, Á. (2010). Compliance and persistence with medications for chronic obstructive pulmonary disease. Clinical and Experimental Medical Journal, 4(1), 15-22. doi: 10.1556/cemed.4.2010.28691 Link
Agh, T., Bartfai, Z., Meszaros, A. (2010). Relation of adherence to quality of life in COPD patients. [in Hungarian]. MEDICINA THORACALIS 63: 197
Agh, T., Bodnar, R., Agh, L. (2010). The importance of quality of life monitoring in the management of asthma [in Hungarian]. MEDICUS UNIVERSALIS 43: 179-181.
Agh, T., Meszaros, A. (2010). Pharmacoeconomic impact of compliance [in Hungarian]. ACTA PHARMACEUTICA HUNGARICA 80: 75-80. Link
Antal, J., Szepezdi, Zs., Nagyjánosi, L., Kaló, Z. (2010). A nemzetközi klinikai vizsgálatok helyzete és hozadéka Magyarországon. IME, 2010. 10. 1. 5-10. Link
Bodrogi, J., Kaló, Z. (2010). Principles of pharmacoeconomics and their impact on strategic imperatives of pharmaceutical research and development. British Journal of Pharmacology, 159(7), 1367-1373. doi: 10.1111/j.1476-5381.2009.00550.x Link
Inotai, A., Hankó, B., Mészáros, Á. (2010). Trends in the non-steroidal anti-inflammatory drug market in six Central-Eastern European countries based on retail information. Pharmacoepidemiology and Drug Safety, 19(2), 183-190. doi: 10.1002/pds.1893 Link
Inotai, A., Kalo, Z. (2010). The assessment of innovation and the R&D&I strategy of public health care sector [in Hungarian]. EGESZSEGUGYI GAZDASAGI SZEMLE 48: 33-38.
Inotai, A., Meresz, G., Kalo, Z. (2010). Assessment of the pharmaceutical expenditure in Hungary [in Hugarian]. ACTA PHARMACEUTICA HUNGARICA 80: 162-172. Link
Inotai, A., Rojkovich, B., Meszaros, A. (2010). The assessment of oral NSAID use in patients with rheumatoid arthritis in Hungary-a cross sectional non interventional study. [in Hungarian] ACTA PHARMACEUTICA HUNGARICA 80: 47-54. Link
Kaló, Z., Józwiak-Hagymásy, J., Németh, A. (2010). A napi adagolás, mint a beteg-együttműködést befolyásoló tényező –vizsgálata szkizofréniában szenvedő betegek körében. IME, 2010. 9. 5. 37-42. Link
Kalo, Z., Kiss, Z., Gerendy, P., Nagyjanosi, L., Voko, Z. (2010). COST OF RENAL REPLACEMENT THERAPY IN HUNGARY. Transplantation Journal, 90, 735. doi: 10.1097/00007890-201007272-01416 Link
Kaló, Z., Kovács, A., Margitai, B., Mészner, Zs., Vokó, Z. (2010). „Value of vaccine – A védőoltás érték” program Fehér Könyve. IME, 2010. 10. 1. 39-44. Link
Kaló, Z., Vokó, Z. (2010). A kockázatmegosztás szerepe a gyógyszerek finanszírozásában. Lege Artis Medicinae 2010. 20. 3-4. 237-241 Link
Kuchinke, W., Ohmann, C., Yang, Q., Salas, N., Lauritsen, J., Gueyffier, F., Leizorovicz, A., Schade-Brittinger, C., Wittenberg, M., Voko, Z., Gaynor, S., Cooney, M., Doran, P., Maggioni, A., Lorimer, A., Torres, F., McPherson, G., Charwill, J., Hellström, M., Lejeune, S. (2010). Heterogeneity prevails: the state of clinical trial data management in Europe - results of a survey of ECRIN centres. Trials, 11(1). doi: 10.1186/1745-6215-11-79 Link
Nagy, B. (2010). Resource allocation in Hungarian health care - Is there a missing link? [in Hungarian]. KOZGAZDASAGI SZEMLE 57:4 337-353. Link
Orosz, M., Galffy, G., Agh, T., Kovacs, D., Meszaros, A. (2010). The everyday life of patients with asthma or COPD. [in Hungarian]. MEDICINA THORACALIS 63: 181-182.
Vokó, Z., Danchin, N., de Brouwer, S., Kirwan, B.-A., Poole-Wilson, P. A., Lubsen, J. (2010). Correlates of coronary angiography in patients with stable angina and geographical differences in its utilisation: The ACTION experience. International Journal of Cardiology, 138(1), 56-62. doi: 10.1016/j.ijcard.2008.08.036 Link
Vokó, Z., Nagyjánosi, L., Kaló, Z. (2010) Cost-effectiveness analysis of adding HPV vaccination to cervical cancer screening program in Hungary. Value in Health, 13:(7) pp. A270-A271. Link
2009
Agh, T., Agh, L. (2009). The significance of medication compliance and persistence in hypertension, diabetes mellitus and dyslipidemia [in Hungarian]. MEDICUS UNIVERSALIS 42: 3-6. (2009)
Agh, T., Meszaros, A. (2009). Compliance and persistence with medication in chronic obstructive pulmonary disease [in Hungarian]. ORVOSI HETILAP 150: 1497-1502. doi: 10.1556/OH.2009.28691 Link
Inotai, A., Kalo, Z., Meszaros, A. (2009). Decision analytic modeling and their impact on health care decision making. [in Hungarian] ACTA PHARMACEUTICA HUNGARICA 79: 63-69. Link
Inotai, A., Mészáros, Á. (2009). Economic evaluation of nonsteroidal anti-inflammatory drug strategies in rheumatoid arthritis. International Journal of Technology Assessment in Health Care, 25(02), 190-195. doi: 10.1017/s0266462309090242 Link
Kaló, Z. (2009). Az egészség-gazdaságtani elemzések és az objektív támogatáspolitikai rendszer dilemmái Magyarországon. Lege Artis Medicinae, 2009. 19. 4–5. 329–333. Link
Kaló, Z., Bors, K., Dank, M., Géczi, L., Horváth, Cs., Jermendy, Gy., Kalotai, Z., Kincses, J., Margitai, B., Novákné Pékli, M., Vasvári, A., Thurzó, L., Vokó, Z., Winkler, G., Zalatnainé Tóth, K. (2009). Együtt az egészségért: az életminőség mérésének jelentősége a bizonyítékokon alapuló egészségpolitikai döntéshozatalban. Orvostovábbképző Szemle. 2009. 16. 9. 12-14.
Marton, I., Masszi, T., Kaló, Z. (2009). A Transzparencia Direktíva implementálásának kérdései a deferazirox ártámogatása kapcsán. IME, 2009. 8. 1. 40-44. Link
Nagy, B., Brandtmuller, A., Dozsa, Cs. (2009). The Redistributive Role of the State in the British and Dutch Health Care Market. Is there another Way? [in Hungarian] TARSADALOMKUTATAS (SOCIAL SCIENCE RESEARCH) 27: 2117-2138. Link
Nagy, B., Brennan, A., Skultety, L., Nagy, J., Szentesi, A., Dessewffy, Z., Kalotai , Z. (2009). The cost effectiveness of rivastigmine transdermal patch in the management of patients with mild and moderate Alzheimer’s disease [in Hungarian]. IME 8:3 40-45. Link
Voko, Z., Csepe, P., Nemeth, R., Kosa, K., Kosa, Z., Szeles, G., Adany, R. (2009). Does socioeconomic status fully mediate the effect of ethnicity on the health of Roma people in Hungary? Journal of Epidemiology & Community Health, 63(6), 455-460. doi: 10.1136/jech.2008.079715 Link
Voko, Z., Nagyjanosi, L., Kalo, Z. (2009). Direct health care costs of diabetes mellitus in Hungary [in Hungarian], LEGE ARTIS MEDICIANE 19(12):775-780. Link
2008
Bhalla, A., Grieve, R., Rudd, A. G., Wolfe, C. D. A. (2008). Stroke in the Young: Access to Care and Outcome; A Western Versus Eastern European Perspective. Journal of Stroke and Cerebrovascular Diseases, 17(6), 360-365. doi: 10.1016/j.jstrokecerebrovasdis.2008.04.002 Link
Inotai, A., Meszaros, A. (2008). Cost effectiveness of celecoxib in rheumatoid arthritis [in Hungarian], IME 7: 48-50. Link
Inotai, A., Vincze, Z. (2008). Cost study of NSAID use in rheumatoid arthritis based on recent therapeutic protocols [in Hungarian], ACTA PHARMACEUTICA HUNGARICA 78: 79-86. Link
Kaló, Z., Nagy, B. (2008). Paradigmaváltás a preventív egészségügyi befektetések gazdasági megítélésében – Hogyan mérjük egy védőoltás költséghatékonyságát? IME, 2008. 7. 8. 42-45. Link
Nagy, B., Brandtmüller, Á. (2008). Implementing Risk Adjusted Capitation Payments with Health Care Reforms in Hungary. Competitio, 7(2), 147-160. doi:10.21845/comp/2008/2/8 Link
Nagy, B., Kaló, Z., Hegyi, R. (2008) Paradigmaváltás a preventív egészségügyi befektetések gazdasági megítélésében III. IME, 2008. 7. 10. 24-29. Link
Nagy, B., Kaló, Z. (2008). Paradigmaváltás a preventív egészségügyi befektetések gazdasági megítélésében - Egészséges társadalom és gazdasági növekedés: ok és okozat? IME, 2008. 7. 7. 37-40. Link
Nagy, B., Rakonczai, P., Gulacsi, L. (2008) Application of statistical methods to calculate capitation payments in the Hungarian health care. [in Hungarian] STATISZTIKAI SZEMLE (HUNGARIAN STATISTICAL REVIEW) 86:4 321-341. Link
Nagy, B., Rakonczai, P., Sipos, J. (2008). Predicting health care expenditures with demographic characteristics for designing capitation payments in Hungary [in Hungarian]. IME 7:Egeszseg-gazdasagtani kulonszam 5-9. Link
Takemoto, S. K., Arns, W., Bunnapradist, S., Garrison, L. P., Guirado, L., Kalo, Z., Oniscu, G., Opelz, G., Scolari, M. P., Stefoni, S., Yaqoob, M., Brennan, D. C. (2008). Expanding the Evidence Base in Transplantation: The Complementary Roles of Randomized Controlled Trials and Outcomes Research. Transplantation, 86(1), 18-25. doi: 10.1097/tp.0b013e31817d4df5 Link
